altern
effici
viral
vector
gene
therapi
desir
poor
safeti
profil
chitosan
promis
nonvir
nucleotid
deliveri
vector
biocompat
biodegrad
low
immunogen
eas
manufactur
sinc
transfect
effici
chitosan
polyplex
rel
low
compar
viral
counterpart
impetu
gain
better
understand
structureperform
relationship
recent
progress
prepar
characteris
enabl
coupl
analysi
chitosan
structur
paramet
led
increas
te
tailor
chitosan
structur
review
summar
recent
advanc
lead
ration
design
chitosan
polyplex
present
integr
review
major
area
chitosanbas
transfect
includ
prepar
chitosan
polyplex
physicochem
characteris
vitro
vivo
assess
present
obstacl
effici
transfect
strategi
adopt
time
surmount
impedi
concept
gene
therapeut
publish
earli
scienc
initi
focu
genet
defect
insert
exogen
dna
cell
use
attenu
virus
replac
defect
dna
although
viral
vector
still
current
domin
field
gene
transfer
high
effici
increas
interest
develop
nonvir
gene
deliveri
system
overcom
viral
safeti
issu
immunogen
insert
mutagenesi
nonvir
nucleic
acid
na
deliveri
system
also
gener
endow
inher
formul
flexibl
lower
manufactur
cost
moreov
interest
field
nonvir
vector
gain
new
momentum
recent
due
need
effect
deliveri
system
small
interf
rna
sirna
nucleotid
duplex
induc
specif
mrna
cleavag
via
rna
interfer
nobel
prize
promis
new
major
class
pharmaceut
therapeut
mulligan
publish
natur
use
nonvir
techniqu
calcium
phosphat
introduc
foreign
dna
mammalian
cell
nonvir
vector
broadli
classifi
two
categori
exclud
vector
free
system
electropor
calcium
phosphat
cation
lipid
propan
dotap
n
n
n
ntrimethylammonium
chlorid
dotma
ii
cation
polym
polyethylenimin
pei
poli
llysin
pll
chitosan
cs
cation
lipid
polym
design
form
liposom
nanocomplex
respect
neg
charg
na
mean
electrostat
complex
format
although
cation
lipid
studi
nonvir
system
date
associ
signific
vitro
vivo
toxic
cation
polym
shown
particularli
promis
among
nonvir
vector
success
nucleotid
deliveri
vitro
vivo
cation
polym
display
less
toxic
associ
cytokin
induct
compar
cation
lipid
counterpart
among
chitosanderiv
vector
garner
increas
interest
chitosan
naturallyderiv
biocompat
biodegrad
mucoadhes
nontox
polym
chitosan
compos
glucosamin
nacetylglucosamin
unit
approv
use
sever
medic
applic
wound
dress
hemostat
patch
hemcon
pleas
see
tabl
refer
exhaust
list
chitin
chitosanbas
product
use
wound
dress
chitosanbas
biomateri
discov
develop
part
group
shown
improv
cartilag
repair
anim
model
product
sinc
complet
clinic
trial
evalu
piram
healthcar
canada
receiv
european
regulatori
approv
chitosanbas
cartilag
repair
product
bstcargel
improv
understand
structurefunct
relationship
chitosan
base
deliveri
system
past
decad
enabl
signific
optim
famili
deliveri
system
chitosan
one
studi
polym
nucleotid
deliveri
subject
mani
review
specif
focu
target
deliveri
pdna
sirna
formul
influenc
vitro
effici
base
signific
advanc
chitosanbas
polynucleotid
deliveri
one
may
expect
emerg
shortli
success
clinic
trial
aim
review
highlight
recent
develop
improv
understand
chitosanbas
na
system
identifi
current
limit
encount
field
produc
integr
review
main
aspect
chitosanbas
polynucleotid
deliveri
includ
sourc
prepar
character
vitro
vivo
assess
eye
toward
achiev
clinic
applic
although
braconnot
discov
chitin
cell
wall
mushroom
rouget
extract
chitosan
insect
chitin
polysaccharid
first
industri
extract
marin
organ
elimin
fisheri
wast
coastal
region
wast
quickli
lead
decreas
oxygen
content
water
land
sourc
environment
public
health
concern
knowledg
sourc
chitin
critic
ensur
repeat
differ
batch
medic
applic
et
al
review
prepar
chitin
marin
organ
comput
variat
chitin
content
differ
speci
conclud
base
kurita
exoskeleton
compos
chitin
protein
calcium
carbon
necessari
specifi
sourc
chitin
whether
sourc
mixtur
differ
speci
although
sever
review
affirm
season
variat
chitin
content
exoskeleton
et
al
observ
chang
chitin
content
differ
season
deep
water
shrimp
pandalu
boreali
season
variat
may
depend
speci
method
also
develop
extract
chitin
terrestri
organ
insect
mushroom
nwe
et
al
review
differ
terrestri
sourc
chitin
primarili
insect
mosquito
cockroach
honeybe
case
marin
organ
industri
product
chitin
involv
use
insect
wast
exampl
nemtsev
et
al
show
honeybe
compos
chitin
protein
melanin
miner
paulino
et
al
also
extract
chitin
dead
silkworm
larva
bodi
presenc
melanin
coval
bond
chitin
drawback
given
difficulti
dissoci
two
product
case
nemtsev
degrad
melanin
residu
still
present
chitin
extract
chitin
fungi
also
develop
mushroom
possibl
grow
singl
speci
throughout
year
howev
low
chitin
content
challeng
industri
product
chitin
knezevicjugov
et
al
conclud
base
sever
studi
content
chitin
chitosan
dri
mycelia
percentag
chitin
dri
biomass
depend
natur
cultur
media
demonstr
chatterje
et
al
mucor
rouxii
stamford
et
al
cunninghamella
elegan
mushroom
chatterje
also
observ
variat
crystallin
variat
cultur
media
use
grow
speci
particular
issu
chitosan
mushroom
glucan
chain
coval
bond
chitin
remain
difficult
elimin
given
multipl
possibl
origin
chitin
evid
detail
descript
locat
speci
given
well
appreci
potenti
side
product
contamin
melanin
glucan
chain
etc
absenc
verifi
biomed
applic
moreov
depend
origin
chitin
structur
vari
demand
chang
specif
extract
protocol
chitin
semicrystallin
polym
mainli
crystallin
form
allomorph
amorph
compon
differ
crystallin
region
common
occur
marin
terrestri
live
organ
fungal
cell
wall
less
common
found
certain
speci
recent
review
rinaudo
summar
differ
speci
produc
squid
pen
tube
synthes
pogonophoran
vestimetiferan
worm
third
allophorm
present
cocoon
fiber
ptinu
beetl
stomach
loligo
seem
variant
nacetyldglucosamin
chiral
sinc
glycosid
bond
link
unit
chitin
chain
also
consid
chiral
form
chain
organ
sheet
intrasheet
hydrogen
bond
bind
chain
crystallin
form
specif
three
allomorph
depend
chain
stack
adjac
chain
orient
opposit
direct
allow
strong
intraand
intersheet
hydrogen
bond
hydroxymethyl
group
lead
strong
crystal
form
solvent
difficulti
penetr
chain
orient
direct
weak
intrasheet
hydrogen
bond
result
higher
affin
solvent
upon
dissolut
strong
acid
media
hno
hcl
convert
invari
irrevers
differ
allomorph
part
respons
variabl
chitin
properti
impos
certain
restrict
extract
process
chitin
raw
materi
describ
shown
fig
four
step
requir
extract
chitin
raw
materi
marin
exoskeleton
insect
fungi
first
step
grind
siev
necessari
maxim
chitin
extract
remov
unwant
product
depend
upon
natur
raw
materi
target
molar
mass
degre
deacetyl
dda
chitin
subsequ
step
need
adjust
second
step
usual
deprotein
dp
deminer
dm
although
dp
dm
may
also
revers
protein
recoveri
dri
treatment
chitin
may
decolor
dc
dp
carri
treatment
mild
alkali
solut
naoh
koh
na
co
k
co
naoh
often
use
time
temperatur
treatment
depend
origin
raw
materi
chitin
insect
fungi
coval
bond
protein
requir
stronger
treatment
crystallin
form
chitin
target
dda
sinc
alkali
condit
may
deacetyl
chitin
miner
mainli
caco
ca
po
also
miner
salt
remov
use
acid
dm
step
acid
use
hcl
hno
h
ch
cooh
hcooh
hcl
prefer
reagent
hydrolysi
polym
chain
may
occur
dm
treatment
strong
percot
et
al
optim
step
shell
marin
shrimp
parapenaeopsi
stylifera
found
hcl
room
temperatur
min
suffici
remov
miner
krepet
et
al
succeed
extract
chitin
raw
materi
without
dm
appli
electr
current
dp
step
level
chitin
extract
process
result
product
chitin
brown
brownwhit
product
due
remain
carotenoid
deriv
oxid
like
kmno
h
naocl
use
decolor
dc
bleach
may
subsequ
remov
extract
ethanol
aceton
extract
also
allow
remov
residu
lipid
dc
step
import
biomed
applic
extract
ethanol
aceton
prefer
ensur
maximum
remov
side
product
dp
dm
dc
step
use
larg
amount
water
neutral
acid
base
energi
need
heat
produc
corros
wast
altern
develop
use
biolog
process
jo
et
al
review
differ
microorgan
enzym
use
dm
dp
dm
done
ferment
use
microorgan
wherea
dp
done
bacteri
ferment
proteolyt
enzym
pacheco
et
al
compar
chemic
versu
biolog
use
lactobacillu
plantarum
dm
dp
case
da
result
chitin
similar
weight
averag
molar
mass
w
higher
case
biolog
clean
extract
protein
recov
dp
step
applic
ie
cosmet
biolog
extract
chitin
contain
protein
ash
chemic
extract
chitin
case
dm
dp
may
perform
one
step
rao
et
al
use
l
plantarum
bacteria
compar
chemic
process
show
advantag
bacteri
process
drastic
reduct
chemic
use
still
requir
acid
alkali
treatment
remov
protein
miner
remain
ferment
biolog
product
chitin
elimin
pollut
depolymer
problem
main
drawback
time
consumpt
lower
effici
chemic
extract
particular
import
biomed
use
undesir
residu
protein
chitin
chitosan
prepar
chitin
deacetyl
sever
definit
chitosan
versu
chitin
exist
robert
assum
chitosan
solubl
fraction
polym
solubl
dilut
aqueou
acid
solut
kumar
et
al
chitosan
polysaccharid
element
analysi
nitrogen
content
higher
wt
degre
acetyl
lower
correspond
dda
higher
two
definit
alway
compat
sinc
solubl
depend
dda
also
concentr
molar
mass
furthermor
nitrogen
content
element
analysi
affect
residu
protein
content
third
definit
given
rinaudo
chitin
dda
higher
call
chitosan
seem
appropri
biomed
chitosan
case
gene
deliveri
chitosan
employ
typic
dda
higher
chitosan
obtain
deacetyl
chitin
differ
process
result
properti
vari
accord
method
use
inde
mean
chitin
deacetyl
affect
distribut
nacetyl
amin
group
along
chitosan
chain
homogen
reacetyl
chitosan
display
differ
enzymat
degrad
properti
compar
heterogen
prepar
chitosan
typic
less
degrad
due
random
distribut
acetyl
group
polym
backbon
chitosan
usual
obtain
alkalin
deacetyl
chitin
particul
chitin
suspend
hot
alkalin
solut
typic
ww
naoh
adjust
time
temperatur
allow
wide
rang
dda
produc
acetyl
content
target
alkalin
deacetyl
heterogen
reaction
thought
result
block
distribut
acetyl
group
use
h
nmr
et
al
confirm
heterogen
prepar
chitosan
slightli
blockwis
less
random
distribut
homogen
deacetyl
describ
lamarqu
et
al
studi
role
allomorph
deacetyl
use
xray
diffract
h
nmr
spectroscopi
conclud
crystallin
area
chitin
need
first
becom
amorph
order
deacetyl
case
deacetyl
fast
due
weak
hydrogen
bond
result
acetyl
distribut
random
case
crystallin
domain
initi
avail
naoh
need
time
inert
atmospher
higher
temperatur
thu
result
block
acetyl
distribut
decreas
final
molar
mass
chitosan
avoid
phenomena
lamarqu
et
al
develop
method
freezepump
outthaw
cycl
improv
deacetyl
reduc
chain
cleavag
result
chitosan
higher
molar
mass
random
distribut
amin
group
along
chain
random
distribut
amin
along
chain
also
achiev
dissolv
chitin
ww
naoh
solut
leav
sever
hour
stir
third
method
obtain
random
acetyl
distribut
reacetyl
fulli
deacetyl
chitosan
watermethanol
vv
stoichiometr
amount
acet
anhydrid
desir
dda
extract
chitin
raw
materi
sever
biolog
process
also
develop
use
enzymat
pathway
deacetyl
chitin
zhao
summar
enzymat
modif
chitin
chitosan
enzym
use
deacetyl
part
carbohydr
esteras
famili
defin
cazi
databas
http
wwwcazyorg
chitin
deacetylas
cda
ec
nodb
protein
ec
peptidoglycan
deacetylas
ec
enzym
colletotrichum
lindemuthianum
deuteromycet
atec
main
challeng
enzymat
deacetyl
succeed
deacetyl
crystallin
form
chitin
sinc
crystallin
chitin
may
deacetyl
via
procedur
sever
studi
highlight
length
chitosan
chain
play
crucial
role
gene
deliveri
modul
size
chain
thu
molar
mass
chitosan
glycosid
linkag
saccharid
unit
need
cleav
cleavag
also
call
depolymer
achiev
sever
mean
chitosan
first
depolymer
use
concentr
hcl
falk
et
al
found
concentr
hcl
hydrolysi
glycosid
bond
faster
deacetyl
result
confirm
rupley
method
employ
sever
group
howev
deacetyl
inevit
occur
hcl
lead
increas
dda
enzymat
hydrolysi
chitin
chitosan
propos
altern
method
product
chitinchitosan
oligom
elev
cost
chitosanas
enzym
depolymer
chitosan
chain
mani
studi
done
identifi
mechan
action
effici
enzym
depend
distribut
unit
along
polym
chain
two
kind
chitosanas
exist
exochitosanas
cleav
unit
continu
nonreduc
end
substrat
endochitosanas
ec
specif
famili
glycosid
hydrolas
defin
cazi
databas
http
wwwcazyorg
fukamizo
et
al
classifi
endochitosanas
three
subclass
depend
substrat
specif
chitosanas
subclass
hydrolyz
ad
dd
linkag
subclass
ii
enzym
hydrolyz
dd
linkag
wherea
subclass
iii
enzym
hydrolyz
da
dd
linkag
current
costeffect
method
depolymer
chitosan
second
chemic
method
involv
use
nitrou
acid
hono
propos
allan
et
al
select
depolymer
hono
attack
amin
group
without
deacetyl
rapid
easili
control
second
advantag
reaction
one
end
cleav
chain
aldehyd
exploit
make
gel
graft
oligom
chitosan
tommeraa
studi
chitosan
depolymer
oligom
low
dp
allow
h
nmr
observ
reduc
end
chain
gem
diol
schiff
base
rather
aldehyd
certain
condit
basic
acid
condit
multipl
step
requir
start
materi
obtain
final
chitosan
appropri
biomed
applic
specif
process
need
chosen
depend
structur
origin
raw
materi
desir
product
rigor
precis
chemic
analysi
requir
character
result
chitosan
sinc
specif
characterist
greatli
affect
experiment
find
vitro
vivo
describ
sever
paramet
need
precis
determin
use
chitosan
biomed
applic
particularli
gene
deliveri
chitosan
ad
list
excipi
american
societi
test
materi
astm
also
publish
standard
guid
character
test
chitosan
salt
start
materi
intend
use
biomed
tissueengin
medic
product
applic
standard
suggest
use
infrar
spectroscopi
ir
fourier
transform
infrar
spectroscopi
ftir
identifi
polym
infrar
spectrum
show
absorpt
band
relat
bend
stretch
uniqu
bond
result
spectrum
fingerprint
product
chitosan
identifi
sever
absorpt
band
specif
wavenumb
tabl
h
c
nmr
also
use
identifi
chitosan
via
particular
chemic
shift
proton
carbon
tabl
dda
degre
deacetyl
one
import
paramet
character
chitosan
especi
gene
deliveri
inde
dda
determin
allow
knowledg
averag
amount
amin
avail
interact
na
strongli
influenc
degrad
inflamm
immun
modul
kasaai
review
differ
method
use
dda
determin
summar
moreov
usp
h
nmr
recommend
dda
determin
wherea
astm
edit
test
h
nmr
uv
spectroscopi
advis
astm
determin
dda
uv
spectroscopi
base
muzzarelli
et
al
studi
contrari
state
standard
quantit
measur
number
acetyl
group
polym
wavelength
nm
number
amin
group
allow
determin
dda
dda
calcul
build
calibr
curv
variou
concentr
nacetyl
glucosamin
monom
method
sensit
chitosan
sampl
need
absolut
dri
determin
accur
concentr
polym
solut
need
minimum
concentr
nacetyl
glucosamin
monom
good
accuraci
presenc
residu
protein
may
affect
measur
gene
deliveri
chitosan
often
high
dda
thu
problemat
method
quantifi
acetyl
group
reason
h
nmr
recommend
determin
dda
dda
h
nmr
spectroscopi
use
h
nmr
measur
chitosan
dda
fast
method
need
calibr
curv
standard
affect
water
content
contrast
uv
method
recommend
dissolv
chitosan
deuter
formic
acid
use
averag
area
region
contain
nonacetyl
proton
ppm
int
area
methylen
group
nacetyl
calcul
dda
accord
formula
dda
int
h
ac
even
chitosan
complet
dri
deuter
formic
acid
fresh
hdo
peak
ppm
chemic
shift
rel
sodium
trimethylsilyl
propanesulfon
standard
result
overestim
integr
ppm
lead
error
follow
altern
calcul
method
precis
determin
dda
h
nmr
specif
astm
standard
astm
publish
dda
determin
h
nmr
method
base
chitosan
need
first
depolymer
degre
depolymer
dp
nitrou
acid
prior
analysi
enhanc
qualiti
spectra
especi
chitosan
low
dda
precipit
low
temperatur
calcul
dda
done
follow
eq
h
h
integr
proton
h
h
monom
ppm
h
ac
integr
three
proton
acetyl
group
ppm
h
integr
anomer
proton
monom
ppm
h
integr
anomer
proton
monom
ppm
drawback
method
hono
step
prepar
sampl
need
time
prepar
use
proton
h
h
sinc
region
spectra
affect
case
modif
chitosan
exampl
poli
ethylen
glycol
graft
chitosan
recommend
altern
develop
accur
method
determin
dda
use
h
h
ac
use
high
dda
h
ac
peak
correspond
three
proton
certain
modifi
chitosan
via
follow
other
techniqu
acid
base
potentiometr
titrat
conductometri
c
n
nmr
colloid
titrat
ninhydrin
assay
element
analysi
also
summar
kasaai
less
accur
need
treatment
prior
analysi
may
sensit
sideproduct
infrar
especi
recommend
dda
ir
band
strongli
affect
presenc
water
impur
distribut
acetyl
amin
group
along
chitosan
chain
slightli
depend
mode
deacetyl
character
h
c
nmr
et
al
weinhold
et
al
conclud
chitosan
close
random
distribut
acetyl
amin
group
heterogen
deacetyl
chitosan
perhap
reason
analysi
mention
standard
molar
mass
anoth
critic
import
characterist
chitosan
permit
assess
averag
number
monom
per
chain
dispers
relat
actual
distribut
chain
length
sampl
h
nmr
specif
astm
standard
standard
test
method
determin
molar
mass
chitosan
chitosan
salt
size
exclus
chromatographi
sec
multi
angl
light
scatter
detect
sec
mal
publish
chitosan
molar
mass
determin
section
treat
molar
mass
determin
also
present
suggest
method
accur
specifi
astm
inde
use
calibr
curv
peg
pullulan
standard
recommend
sinc
chitosan
polyelectrolyt
hydrodynam
radiu
larger
noncharg
polym
molar
mass
exclus
volum
use
sec
coupl
mal
measur
absolut
massaverag
molar
mass
necessari
obtain
chitosan
molar
mass
number
mass
averag
molar
mass
chitosan
eq
dispers
eq
radiu
gyrat
r
g
second
virial
coeffici
eq
determin
use
sec
multi
angl
light
scatter
mal
detect
coupl
refractomet
detector
eq
c
concentr
polym
measur
refractomet
n
number
molecul
molar
mass
w
mass
molecul
specif
molar
mass
use
mal
involv
static
light
scatter
theori
determin
w
r
g
eq
nevertheless
gene
deliveri
number
averag
molar
mass
n
recommend
allow
better
understand
number
amin
avail
per
chain
rayleighgansdeby
rgd
approxim
power
gener
light
scatter
theori
applic
particl
much
smaller
wavelength
light
measur
scatter
light
depend
sever
factor
explic
eq
equat
excess
rayleigh
ratio
r
ratio
scatter
incid
light
intens
take
account
differ
factor
includ
angl
distanc
detector
scatter
volum
incid
light
intens
volum
sampl
illumin
eq
c
mass
concentr
solut
gml
w
weight
averag
molar
mass
gmol
second
virial
coeffici
mol
mlg
scatter
angl
angl
incid
beam
scatter
signal
p
form
factor
scatter
function
relat
angular
variat
scatter
intens
root
mean
squar
radiu
rg
particl
k
follow
optic
constant
eq
n
refract
index
solvent
incid
wavelength
incid
wavelength
express
nm
n
avogadro
number
dndc
refract
index
increment
solventsolut
solut
respect
chang
solut
concentr
express
mlg
dndc
must
measur
independ
use
refractomet
detector
sec
mal
comput
molar
mass
depend
upon
dndc
first
order
use
onlin
refract
index
detector
determin
polym
concentr
wherea
batch
type
experi
concentr
polym
determin
independ
molar
mass
depend
squar
dndc
paramet
specif
polym
also
depend
mobil
phase
employ
wavelength
incid
light
tabl
summar
protocol
chitosan
employ
sever
sec
studi
surprisingli
despit
slight
chang
mobil
phase
composit
wavelength
wide
rang
refract
index
increment
dndc
chitosan
calcul
studi
found
depend
dndc
dda
wherea
other
use
averag
valu
sinc
coeffici
variat
low
good
accuraci
recommend
measur
dndc
specif
chitosan
mobil
phase
use
sec
system
prior
analysi
sever
mobil
phase
also
propos
sec
mani
compos
acet
acid
acoh
sodium
acet
acona
also
ammonium
acet
aconh
although
ammonium
acet
recommend
astm
christensen
et
al
observ
instabl
attribut
volatil
aconh
ri
signal
thu
acona
advis
mobil
phase
prepar
anthonsen
et
al
observ
high
molecular
weight
compon
depend
concentr
polym
sever
subsequ
studi
confirm
phenomena
schatz
et
al
found
aggreg
suggest
acetyl
group
drove
format
aggreg
wherea
sorlier
et
al
conclud
degre
ioniz
also
play
role
phenomena
recent
popanita
et
al
suggest
hydrophob
interact
explan
avoid
presenc
aggreg
sever
mobil
phase
propos
nguyen
et
al
compar
two
princip
composit
acona
acona
conclud
latter
allow
better
molar
mass
determin
without
observ
aggreg
although
standard
astm
recommend
dissolv
chitosan
base
acet
acid
solut
shake
min
overnight
cool
temperatur
moll
ammonium
acet
solut
altern
directli
solubil
chitosan
mobil
phase
overnight
use
markhouwink
equat
km
measur
intrins
viscos
knowledg
k
markhouwink
paramet
chitosan
studi
solvent
provid
viscometricaverag
molar
mass
v
howev
formula
empir
calcul
mass
rigor
molar
mass
determin
light
scatter
avoid
use
sec
coupl
mal
refractomet
minimum
measur
absolut
molar
mass
polydispers
chitosan
brugnerotto
et
al
observ
ir
chitosan
hygroscop
polym
determin
water
content
dri
mass
must
done
prepar
solut
precis
concentr
astm
refer
usp
test
n
g
chitosan
dri
oven
h
weigh
water
content
lower
mass
addit
requir
character
insolubl
character
insolubl
requir
astm
allow
determin
insolubl
impur
filter
solut
chitosan
dilut
acet
acid
weigh
remain
chitosan
mass
insolubl
collect
filter
specifi
astm
content
low
possibl
biomed
applic
ash
content
residu
ignit
residu
ignit
sampl
repres
quantiti
inorgan
matter
sampl
astm
use
test
valu
must
lower
heavi
metal
content
chitosan
form
complex
metal
ion
determin
heavi
metal
content
essenti
determin
specif
heavi
metal
content
necessari
stipul
metal
quantifi
pb
hg
cr
ni
cd
fe
use
induct
coupl
plasma
icp
follow
method
iii
usp
b
maxim
valu
summar
tabl
endotoxin
content
endotoxin
pyrogen
high
molar
mass
lipopolysaccharid
complex
associ
cell
wall
gramneg
bacteria
surfac
lp
molecul
carri
neg
charg
owe
phosphat
pyrophosph
carboxyl
group
locat
predominantli
lipid
inner
part
core
toxin
structur
molecul
bacteria
recogn
immun
system
pharmaceut
product
necessari
remov
trace
endotoxin
explain
patent
applic
dp
step
treatment
naoh
allow
endotoxin
remov
exact
final
quantif
endotoxin
content
need
base
fda
chitosan
modifi
sever
applic
water
cleans
ion
remov
exampl
fiber
format
enhanc
solubl
chitosan
process
cosmet
drug
deliveri
gene
deliveri
chemic
modif
done
address
certain
issu
chitosan
modifi
enhanc
solubl
physiolog
ph
increas
chitosan
solubl
enhanc
colloid
stabil
chitosanna
particl
allow
longer
circul
time
achiev
graft
certain
polym
peg
dextran
chitosan
specif
cell
also
target
graft
appropri
ligand
like
galactos
liver
cell
chitosan
chitosan
also
modifi
increas
proton
spong
capac
use
arginin
histidin
urocan
acid
imidazol
pei
facilit
endosom
escap
function
assess
modif
review
subsequ
section
essenti
consider
interpret
data
obtain
use
modifi
chitosan
natur
extent
character
final
product
h
nmr
power
tool
chemic
quantif
preferenti
chosen
determin
degre
substitut
nevertheless
h
nmr
spectroscopi
typic
quantifi
proton
alway
accur
bond
identif
presenc
new
bond
confirm
graft
chitosan
obtain
infrar
spectroscopi
newli
creat
bond
still
difficult
observ
comparison
physic
mixtur
ratio
done
darra
et
al
graft
ligand
amin
function
chitosan
compar
graft
polym
physic
mixtur
amount
ligand
chang
amid
ii
band
due
graft
molecul
evid
chitosan
modifi
chemic
graft
molecul
polym
amin
hydroxyl
function
hydroxyl
less
reactiv
difficult
use
tabl
along
fig
summar
differ
modif
chitosan
chemic
synthesi
perform
date
princip
drawback
use
chitosan
amin
function
group
modif
group
ioniz
basi
electrostat
complex
anion
phosphat
group
na
modif
may
gener
steric
hindranc
decreas
number
ioniz
amin
bind
na
nonbond
pair
electron
primari
amin
chitosan
nonetheless
good
candid
nucleophil
attack
allow
sever
reaction
tabl
fig
quatern
quatern
chitosan
perform
improv
solubl
physiolog
ph
two
method
quatern
perform
ntrialkyl
use
halogenoalkan
usual
ch
reaction
quatern
epoxid
modif
halogenoalkan
precis
character
requir
sinc
sieval
et
al
demonstr
depend
method
synthesi
ndimethylalkyl
obtain
snyman
et
al
also
observ
oalkyl
hydroxyl
amid
amid
one
common
techniqu
graft
molecul
polym
amin
chitosan
achiev
use
carboxyl
compound
carbodiimid
edc
carbodiimid
hydrochlorid
dcc
dicyclohexyl
carbodiimid
coupl
nh
nhydroxysulfosuccinimid
acceler
reaction
sever
speci
graft
includ
amino
acid
arginin
histidin
galactosyl
lactobion
acid
imidazol
deriv
acid
peg
amid
also
carri
succinimidyl
ester
moieti
directli
react
primari
amin
chitosan
peg
often
graft
method
fluoresc
probe
like
texa
red
character
rigor
clearli
demonstr
amid
bond
form
ir
darra
et
al
sinc
carboxyl
form
speci
bind
electrostat
proton
amin
chitosan
reduct
nalkyl
reduct
nalkyl
method
graft
aldehyd
deriv
amin
chitosan
first
schiff
base
form
amin
aldehyd
result
imin
reduc
addit
reduc
agent
nacnbh
nabh
graft
speci
includ
fluoresc
probe
phosphorylcholin
oligosaccharid
dimer
chitosan
dimer
hexam
polym
dextran
reduct
nalkyl
also
perform
oxid
chitosan
first
chitosan
oxid
kio
result
product
modifi
dunit
sugar
ring
open
two
aldehyd
form
two
aldehyd
react
primari
amin
pei
drawback
method
oxid
step
vold
et
al
observ
reduct
molar
mass
chitosan
concentr
fig
modif
amin
function
group
chitosan
see
tabl
scheme
summar
modif
done
amin
function
chitosan
aldehyd
increas
chitosan
accur
measur
molar
mass
requir
sulfonamid
thiurea
polymer
sulfur
bond
addit
method
use
modifi
chitosan
graft
fluoresc
probe
achiev
ishii
et
al
sulforhodamin
graft
chitosan
wherea
et
al
graft
rhodamin
b
thioisocyan
bind
pei
chitosan
wong
et
al
directli
polymer
pei
amin
chitosan
via
cation
ring
open
polymer
azaridin
acid
condit
lu
et
al
attach
pei
chitosan
first
transform
chitosan
via
maleic
anhydrid
succin
anhydrid
ad
pei
modifi
polysaccharid
recent
chang
et
al
succeed
graft
histidin
dendrim
chitosan
via
disulfid
bond
final
morri
et
al
trimethyl
chitosan
graft
amino
acid
ad
galactosyl
peg
hydroxyl
group
also
modifi
due
high
reactiv
amin
group
must
first
protect
tabl
fig
chitosan
amin
protect
challeng
sinc
group
need
proton
solubl
commonli
employ
protect
group
phthalic
anhydrid
recent
cai
et
al
protect
amin
electrostat
interact
sodium
dodecylsulf
sd
subsequ
step
need
organ
media
otherwis
protect
may
compromis
protect
sever
modif
carri
increas
posit
charg
avail
complex
format
na
follow
galactosyl
peipeg
addit
lastli
rinaudo
et
al
synthes
ncarboxylmethyl
chitosan
reaction
chloroacet
acid
modifi
polym
character
author
proven
direct
indirect
method
chitosan
modifi
studi
cytotox
transfect
effici
studi
case
modif
affect
cell
viabil
wherea
modif
impact
size
complex
transfect
effici
detail
subsequ
section
case
chitosan
modifi
increas
proton
spong
capac
effect
ad
proton
spong
speci
also
discuss
polyc
use
complex
deliv
na
chitosanna
particl
gener
prepar
fast
addit
mix
chitosan
na
solut
dilut
condit
mgml
chitosanna
particl
prepar
manner
constitut
particular
type
polyelectrolyt
complex
pec
prior
treat
detail
prepar
properti
chitosanna
pec
use
summar
gener
properti
pec
associ
character
method
tabl
mix
opposit
charg
polyelectrolyt
pel
result
spontan
format
polyelectrolyt
complex
pec
via
process
mainli
driven
strong
electrostat
attract
nonvir
gene
deliveri
mainli
reli
use
cation
speci
polyc
cation
lipid
form
complex
na
dna
rna
refer
respect
polyplex
lipoplex
system
object
intens
research
sinc
first
use
deliv
dna
depend
natur
pel
mix
condit
media
composit
mix
stoichiometri
pel
concentr
watersolubl
molecular
level
colloid
pec
ie
compris
mani
chain
speci
particl
may
form
dilut
condit
mgml
limit
case
result
structur
solubl
colloid
polyelectrolyt
complex
model
ladderlik
structur
complex
form
molecular
scale
tabl
scheme
summar
modif
done
alcohol
amin
alcohol
function
chitosan
conform
adapt
scrambledegg
structur
contain
larg
number
pel
per
particl
respect
product
solubl
pec
requir
special
prepar
condit
identifi
pioneer
work
kabanov
tsuchida
solubl
pec
form
polyion
significantli
differ
molecular
weight
bear
weak
ionic
group
mix
nonstoichiometr
ratio
presenc
minim
amount
salt
practic
applic
colloid
pec
form
dilut
condit
best
knowledg
format
solubl
pec
chitosan
na
nt
report
literatur
studi
colloid
pec
format
indic
pec
mainli
spheric
consist
neutral
stoichiometr
core
surround
charg
stabil
shell
compos
excess
polyion
howev
polyplex
form
polyc
plasmid
often
consist
mixtur
globular
toroid
rodlik
structur
properti
pec
influenc
sever
paramet
pel
structur
properti
length
charg
space
mix
regim
molar
mix
ratio
medium
ph
ie
polym
ioniz
ionic
strength
salt
screen
electrostat
interact
solut
enabl
rearrang
process
shown
case
small
amount
salt
significantli
reduc
aggreg
number
pec
ie
number
chain
speci
compris
particl
constitut
mean
control
size
mass
pec
asid
vari
pel
concentr
reduc
ioniz
degre
pel
chang
ph
reduc
bind
affin
influenc
structur
pec
worth
mention
order
abl
elucid
influenc
mix
condit
pel
characterist
pec
properti
mix
process
must
perform
use
dilut
solut
mani
practic
case
mix
perform
dilut
regim
pec
structur
format
mostli
determin
fast
kinet
associ
process
mask
influenc
paramet
polyelectrolyt
structur
ioniz
degre
ionic
strength
solut
contradictori
result
report
literatur
regard
influenc
formul
paramet
like
molecular
weight
chitosan
n
p
ratio
particl
size
could
possibl
explain
differ
mix
concentr
aspect
discuss
section
apart
direct
mix
chitosan
solut
na
solut
sometim
refer
complex
coacerv
method
prepar
method
chitosanbas
nanoparticl
deliveri
na
propos
literatur
among
method
ionic
gelat
method
reli
inclus
small
polyion
tripolyphosp
tpp
na
solut
act
ionic
crosslink
upon
mix
chitosan
note
author
mix
preform
chitosantpp
particl
na
adsorb
surfac
particl
method
rais
concern
regard
na
protect
degrad
ii
inclus
chitosan
matrix
nanoparticl
poli
llactidecoglycolid
plga
nanoparticl
bind
na
virtu
posit
charg
iii
use
selfaggreg
hydrophob
modifi
chitosan
form
nanoparticl
adsorb
na
method
pro
con
produc
particl
differ
physicochem
properti
clear
indic
date
one
techniqu
produc
chitosanbas
nanoparticl
superior
term
deliveri
effici
transfect
effici
direct
mix
chitosan
solut
na
solut
simplest
method
often
use
produc
chitosanbas
nanoparticl
deliveri
na
follow
focu
mainli
prepar
method
worth
mention
system
use
modifi
chitosan
also
prepar
simpl
mix
two
opposit
charg
polyelectrolyt
solut
even
appar
simpl
particl
prepar
method
direct
mix
chitosan
na
solut
sever
differ
procedur
propos
literatur
follow
paramet
vari
chitosan
na
mix
presenc
absenc
salt
buffer
dilut
regim
concentr
regim
mix
perform
mainli
room
temperatur
although
sometim
equal
volum
na
chitosan
solut
unequ
volum
mix
author
report
rapid
mix
solut
ad
one
solut
dropwis
fashion
note
excess
chitosan
use
confer
posit
charg
polyplex
formul
success
transfect
cell
vitro
whatev
mix
condit
use
among
numer
prepar
method
method
includ
sodium
sulfat
dna
solut
mix
perform
base
method
propos
leong
et
al
appear
frequent
howev
littl
evid
literatur
heat
solut
includ
sodium
sulfat
dna
solut
result
polyplex
specif
physicochem
properti
confer
superior
transfect
effici
use
mani
differ
mix
condit
list
ionic
strength
ph
temperatur
buffer
method
mix
mix
concentr
vari
render
difficult
comparison
reconcili
sometim
contradictori
report
influenc
formul
paramet
like
molecular
weight
chitosan
n
p
ratio
polyplex
physicochem
structur
properti
size
morpholog
also
signific
number
paper
present
incomplet
descript
polyplex
prepar
method
situat
limit
simpli
preclud
comparison
studi
well
howev
one
mix
paramet
clear
influenc
result
polyplex
properti
whatev
prepar
condit
use
name
mix
concentr
na
size
polyplex
increas
concentr
na
concentr
increas
discuss
studi
chitosanna
polyplex
focu
biolog
activ
dedic
detail
analysi
actual
format
polyplex
influenc
chitosan
structur
paramet
properti
best
knowledg
systemat
studi
chitosanna
polyplex
physicochem
properti
size
mass
densiti
stoichiometri
morpholog
function
mix
paramet
concentr
ionic
strength
ph
medium
n
p
ratio
mix
regim
yet
report
literatur
situat
specif
chitosan
recogn
finer
character
polyplex
complet
theoret
underpin
mechan
format
greatli
need
gener
apart
requir
better
character
understand
influenc
mix
paramet
result
chitosannucleotid
particl
shortcom
associ
current
prepar
chitosannucleotid
particl
must
overcom
gener
preclin
data
translat
clinic
applic
chitosan
particl
current
prepar
manual
mix
small
volum
chitosan
na
solut
use
within
hour
rais
concern
process
reproduc
serious
limit
quantiti
applic
product
ii
mix
process
must
perform
dilut
condit
order
obtain
stabl
colloid
suspens
small
rel
homogen
nanoparticlesanoth
drawback
limit
deliver
dose
system
requir
develop
concentr
method
postmix
note
shortcom
also
specif
chitosanbas
system
gener
recogn
prepar
nonvir
gene
deliveri
system
necessit
dilut
condit
prepar
near
mgml
na
obtain
small
rel
homogen
nanoparticl
best
knowledg
shortcom
chitosanbas
system
directli
address
literatur
howev
clear
avenu
progress
toward
solut
develop
studi
system
adapt
approach
chitosanna
polyplex
would
benefici
field
chitosanbas
gene
deliveri
system
kinet
polyplex
format
fast
format
time
report
rapid
addit
polyc
solut
na
solut
revers
practic
limit
regard
scalabl
reproduc
homogen
order
overcom
limit
mix
techniqu
devic
propos
literatur
prepar
larg
volum
polyplex
techniqu
reli
inlin
mix
two
pel
solut
via
connector
static
mixer
coupl
dual
syring
vari
mix
speed
kasper
et
al
show
small
homogen
pei
pdna
polyplex
could
prepar
size
polydispers
determin
dynam
light
scatter
dl
increas
higher
pdna
concentr
davi
et
al
also
obtain
small
homogen
peipdna
polyplex
use
static
mixer
pec
two
synthet
polym
also
prepar
jetmix
smaller
pec
obtain
compar
prepar
polyelectrolyt
titrat
ie
slow
addit
polyelectrolyt
solut
one
mean
increas
concentr
polyplex
freezedri
follow
rehydr
use
reduc
volum
success
freezedri
polyplex
report
limit
number
studi
without
concentr
rehydr
certain
amount
excipi
requir
freezedri
concentr
therefor
limit
isoton
requir
freezedri
chitosanna
polyplex
report
literatur
concentr
rehydr
report
studi
use
vacuum
centrifug
also
report
mean
concentr
chitosanna
tangenti
flow
filtrat
tff
also
use
concentr
chitosannucleotid
particl
tff
overcom
main
limit
direct
flow
filtrat
rapid
flux
decreas
time
particularli
indic
applic
concentr
product
requir
diafiltr
requir
buffer
exchang
desalt
compar
concentr
upon
rehydr
freezedri
tff
offer
advantag
concentr
small
solut
isoton
requir
theoret
easili
fulfil
tff
use
nanoparticl
purif
concentr
purpos
point
fine
complet
character
chitosanna
polyplex
greatli
need
better
understand
mechan
format
well
influenc
properti
transfect
effici
chitosanna
particl
character
physicochem
properti
variou
extent
mani
studi
sinc
first
use
deliveri
na
report
mumper
et
al
overview
report
physicochem
properti
chitosannucleotid
particl
influenc
formul
paramet
properti
well
character
techniqu
given
particular
differ
plasmid
dna
sirna
discuss
tabl
provid
list
techniqu
use
could
use
character
chitosanna
particl
gener
believ
smaller
particl
effici
transfect
cell
small
particl
also
requir
reach
variou
organ
eg
particl
nm
requir
cross
liver
fenestra
reach
hepatocyt
addit
surfac
properti
particl
size
might
also
determin
composit
protein
corona
surround
particl
could
determin
particl
biolog
fate
pk
chitosan
polym
therefor
weakli
charg
bare
solubl
neutral
ph
chitosanna
polyplex
surfac
charg
well
colloid
stabil
therefor
reduc
physiolog
ph
particl
prone
aggreg
condit
therefor
import
develop
method
control
size
mass
colloid
pec
time
format
limit
aggreg
place
protein
contain
physiolog
solut
especi
system
deliveri
via
intraven
inject
typic
studi
report
use
chitosan
gene
deliveri
applic
chitosannucleotid
particl
minim
character
size
dynam
light
scatter
dl
dl
analysi
chitosanna
polyplex
typic
reveal
rel
polydispers
nanoparticl
size
valu
usual
zaverag
diamet
report
literatur
chitosanna
polyplex
vari
ten
nm
hundr
nm
depend
prepar
method
concentr
ph
volum
mix
etc
properti
chitosan
na
suspens
medium
use
analysi
note
diamet
high
also
report
particl
case
analyz
condit
colloid
unstabl
undergo
aggreg
size
also
measur
electron
microscopi
atom
forc
microscopi
size
report
microscopi
typic
smaller
valu
obtain
dl
polydispers
particl
sinc
size
distribut
measur
dl
weight
scatter
light
intens
proport
squar
molecular
mass
author
howev
attribut
increas
size
dl
vs
tem
sem
due
fact
particl
fulli
hydrat
character
dl
nt
spheric
empir
volumeweight
size
distribut
dl
size
measur
directli
microscopi
close
convers
dl
diamet
intens
volum
squar
volumeor
numberweight
distribut
must
use
great
care
sinc
accur
valu
refract
index
particl
requir
paramet
precis
known
chitosanna
particl
anoth
techniqu
avail
recent
nanoparticl
track
analysi
nta
base
track
brownian
motion
singl
particl
overcom
sensit
bia
toward
larger
particl
dl
due
intens
weight
dl
measur
see
filip
et
al
evalu
comparison
techniqu
dl
use
nta
yet
report
chitosan
particl
techniqu
would
complement
dl
provid
numberweight
distribut
ie
measur
microscopi
addit
abl
estim
concentr
particl
influenc
mix
concentr
probabl
import
experiment
paramet
control
size
time
polyplex
format
concentr
polyelectrolyt
solut
mix
na
paramet
howev
often
overlook
comparison
formul
paramet
structur
paramet
chitosan
n
p
ratio
comparison
result
two
studi
mix
concentr
differ
factor
provid
clear
illustr
concentr
influenc
size
particl
malmo
et
al
prepar
chitosansirna
particl
use
na
concentr
report
size
rang
nm
n
p
nielsen
et
al
prepar
particl
use
sirna
concentr
mgml
obtain
polydispers
particl
much
larger
size
nm
n
p
studi
also
report
increas
polyplex
size
increas
na
mix
concentr
mani
studi
report
chitosanpdna
polyplex
size
increas
chitosan
molecular
weight
increas
mumper
et
al
maclaughlin
et
al
report
signific
increas
polyplex
size
increas
molecular
weight
chitosan
found
size
increas
nm
nm
chitosan
molecular
weight
pass
kda
kda
chang
size
attribut
reduc
solubl
mobil
longer
chitosan
chain
kopinghoggard
et
al
observ
size
increas
nm
chitosan
molecular
weight
increas
kda
chitosanpdna
polyplex
prepar
use
n
p
ratio
much
less
mark
size
increas
chitosan
molecular
weight
report
hand
studi
report
decreas
size
polyplex
increas
chitosan
molecular
weight
signific
influenc
paramet
polyplex
size
although
exact
reason
contradictori
result
remain
unclear
could
possibl
attribut
differ
polyplex
prepar
method
instanc
huang
et
al
studi
polyplex
prepar
medium
rel
high
ionic
strength
ie
hbssme
buffer
ph
compar
studi
polyplex
prepar
water
presenc
limit
amount
salt
report
elsewher
mix
pdna
low
molecular
weight
chitosan
presenc
buffer
moder
ionic
strength
mm
result
format
larg
aggreg
structur
particl
reduc
colloid
stabil
compar
prepar
high
molecular
weight
chitosan
appear
explan
appar
contradictori
result
regard
influenc
chitosan
molecular
weight
polyplex
size
could
lie
reduc
colloid
stabil
polyplex
prepar
low
molecular
weight
chitosan
stabl
water
aggreg
presenc
salt
also
observ
phenomenon
attribut
size
increas
potenti
inabl
low
molecular
weight
chitosan
fulli
condens
plasmid
dna
howev
studi
polyplex
suspend
pb
like
presenc
salt
close
neutral
ph
resuspens
medium
favor
particl
aggreg
best
knowledg
explan
influenc
chitosan
molar
mass
polyplex
colloid
stabil
propos
literatur
could
high
molecular
weight
chitosan
dangl
end
polyplex
surfac
steric
stabil
particl
phenomenon
observ
polyplex
form
shorter
chain
lack
protrud
end
studi
report
influenc
chitosan
molecular
weight
size
chitosansirna
polyplex
malmo
et
al
holzerni
et
al
report
slight
increas
chitosansirna
size
increas
chitosan
molecular
weight
mittnacht
et
al
report
revers
hand
liu
et
al
observ
influenc
chitosan
molecular
weight
polyplex
size
except
kda
chitosan
form
particl
micron
worth
mention
particl
case
prepar
medium
signific
ionic
strength
probabl
limit
polyplex
colloid
stabil
kda
chitosan
discuss
previous
also
point
polyplex
prepar
condit
use
studi
report
influenc
chitosan
molar
mass
size
chitosansirna
polyplex
significantli
differ
could
explain
contradictori
result
regard
influenc
chitosan
molecular
weight
size
chitosansirna
polyplex
studi
report
influenc
chitosan
dda
polyplex
size
size
measur
dl
reveal
chitosanpdna
polyplex
size
slightli
increas
dda
decreas
attribut
weaker
bind
chitosan
na
stiffen
polym
chain
dda
decreas
anoth
explan
actual
amount
chitosan
chain
bound
polyplex
increas
dda
decreas
achiev
given
n
p
ratio
polyplex
also
consist
find
et
al
accord
polyplex
charg
stoichiometri
ie
n
p
ratio
within
polyplex
independ
dda
note
result
obtain
polyplex
prepar
dropwis
addit
chitosan
pdna
reason
assum
similar
result
would
observ
use
flash
mix
prepar
method
influenc
n
p
ratio
influenc
n
p
ratio
polyplex
size
examin
numer
studi
case
increas
rel
excess
chitosan
vs
na
result
format
polyplex
slightli
larger
size
mao
et
al
report
signific
influenc
n
p
ratio
size
test
somewhat
limit
rang
n
p
ratio
compar
test
studi
least
two
studi
report
decreas
polyplex
size
n
p
ratio
observ
decreas
size
compar
n
p
ratio
n
p
ratio
pdna
probabl
complet
complex
compact
chitosan
n
p
ratio
could
explain
result
howard
et
al
observ
signific
decreas
polyplex
size
increas
n
p
result
probabl
due
concentr
effect
sinc
mix
chitosan
concentr
held
constant
na
concentr
therefor
ten
time
lower
highest
n
p
ratio
dna
vs
sirna
sirna
hundr
time
smaller
pdna
theoret
form
smaller
polyplex
experiment
verifi
long
polyplex
size
compar
similar
prepar
condit
specif
na
mix
concentr
compar
instanc
hydrodynam
diamet
chitosansirna
prepar
dilut
regim
use
chitosan
kda
n
p
found
nm
nm
chitosanpdna
polyplex
prepar
similar
condit
chitosan
kda
n
p
mix
method
also
influenc
size
dropwis
addit
chitosan
dilut
sirna
solut
led
format
larger
polyplex
probabl
aggreg
favor
gradual
travers
polyplex
neutral
point
ie
n
p
ratio
worth
mention
larger
chitosansirna
polyplex
hydrodynam
diamet
hundr
nanomet
report
mani
studi
particl
prepar
use
rel
concentr
na
solut
andor
mix
perform
either
high
ph
high
ionic
strength
overview
influenc
chitosan
modif
discuss
earlier
section
increas
number
public
report
use
modifi
chitosan
gene
deliveri
applic
sinc
modif
differ
natur
expect
variabl
influenc
polyplex
size
format
among
paper
size
polyplex
prepar
unmodifi
modifi
chitosan
compar
particular
modif
report
increas
decreas
significantli
alter
polyplex
size
actual
mani
modif
propos
mean
increas
solubl
chitosan
well
polyplex
colloid
stabil
clearli
defin
influenc
particl
size
stabil
physiolog
media
particular
topic
discuss
detail
section
high
surfac
charg
densiti
chitosanna
polyplex
determin
colloid
stabil
nonster
stabil
formul
correl
higher
cell
uptak
transfect
effici
vitro
zeta
potenti
provid
indirect
measur
particl
surfac
charg
densiti
measur
laser
doppler
velocimetri
numer
studi
valu
report
polyplex
prepar
use
excess
chitosan
vs
na
rang
millivolt
ten
mv
depend
mostli
ph
ionic
strength
measur
media
well
n
p
ratio
lesser
extent
structur
paramet
chitosan
discuss
previous
sinc
pk
chitosan
zeta
potenti
strongli
influenc
ph
chang
near
valu
exampl
reduct
zeta
potenti
mv
ph
pass
report
zeta
potenti
typic
rapidli
increas
ten
mv
n
p
pass
slightli
increas
n
p
increas
latter
reflect
mostli
constant
polyplex
stoichiometri
n
p
increas
slight
zeta
potenti
increas
increas
chitosan
molar
mass
dda
report
influenc
expect
least
dda
sinc
determin
chitosan
charg
densiti
chitosan
modif
often
reli
reaction
chitosan
amino
group
therefor
expect
reduc
zeta
potenti
unless
substitu
also
posit
charg
eg
pei
one
expect
mark
decreas
bulki
hydrophil
substitu
peg
sinc
move
slip
plane
away
polyplex
surfac
final
natur
na
pdna
sirna
nt
report
significantli
chang
effect
formul
paramet
medium
properti
zeta
potenti
discuss
morpholog
chitosanpdna
complex
examin
electron
microscopi
andor
atom
forc
microscopi
numer
studi
case
mixtur
toroid
rodlik
globular
particl
observ
author
report
mostli
spheric
particl
differ
morpholog
report
studi
could
relat
use
differ
mix
condit
andor
use
chitosan
differ
structur
properti
chain
stiff
theoret
predict
determin
morpholog
collaps
structur
chitosan
differ
structur
properti
could
result
format
polyplex
differ
morpholog
modifi
dna
chain
stiff
variou
extent
upon
bind
seem
inclus
polyplex
mix
solut
anoth
polyanion
tripolyphosph
tpp
hyaluron
acid
ha
favor
format
chitosanpdna
polyplex
homogen
mostli
spheric
morpholog
use
modifi
chitosan
also
report
favor
format
spheric
chitosanpdna
polyplex
studi
chitosansirna
polyplex
morpholog
examin
report
mostli
spheric
particl
presenc
increas
proport
rodlik
particl
chitosan
higher
molecular
weight
report
theoret
format
toroid
structur
requir
na
chain
length
significantli
higher
bp
would
explain
absenc
type
structur
chitosansirna
polyplex
pdna
polyplex
inclus
anoth
polyanion
use
modifi
chitosan
appear
result
format
spheric
particl
bind
affin
chitosan
na
determin
chitosan
abil
protect
na
well
polyplex
stabil
turn
greatli
determin
polyplex
transfect
effici
gel
retard
assay
mean
qualit
assess
abil
chitosan
complex
pdna
polyplex
stabil
report
mani
studi
polyplex
incub
variou
condit
eg
presenc
compet
polyanion
heparin
variou
ph
transfect
medium
etc
prior
submit
electrophoresisbas
assay
monitor
dna
dissoci
polyplex
type
experi
reveal
polyplex
form
chitosan
low
dda
low
mn
low
n
p
easili
dissoci
therefor
less
stabl
kopinghoggard
et
al
show
formul
stabl
ie
high
mn
chitosan
dissoci
heparin
much
less
effici
transfect
cell
less
stabl
counterpart
ethidium
bromid
displac
assay
anoth
techniqu
use
analyz
somewhat
quantit
chitosanpdna
polyplex
stabil
addit
influenc
n
p
chitosan
structur
properti
discuss
polyplex
found
less
stabl
high
ph
high
salt
content
gel
retard
ethidium
bromid
displac
assay
qualit
indirectli
assess
chitosan
dna
bind
affin
contrast
isotherm
titrat
calorimetri
itc
combin
singl
set
ident
site
model
ssi
quantifi
bind
constant
chitosan
pdna
depend
ph
ionic
strength
chitosan
structur
properti
bind
constant
rang
nm
found
agreement
result
discuss
bind
constant
found
increas
ph
ionic
strength
decreas
chitosan
dda
molar
mass
increas
similar
itc
experi
perform
determin
chitosan
sirna
bind
affin
sirna
ad
chitosan
solut
ph
low
salt
condit
bind
constant
ten
time
lower
found
pdna
equival
condit
determin
nm
without
signific
influenc
chitosan
molar
mass
rel
insensit
bind
affin
toward
chitosan
molar
mass
contrast
result
obtain
pdna
could
explain
fact
guesthost
role
revers
sirna
na
act
guest
dda
chitosan
properti
expect
influenc
bind
affin
lower
bind
affin
chitosan
sirna
rel
insensit
molar
mass
led
use
larg
n
p
ratio
studi
formul
select
basi
stabil
evalu
gel
retard
assay
howev
gel
retard
assay
perform
buffer
higher
physiolog
ph
condit
chitosan
bare
charg
polyplex
therefor
easili
dissoci
particularli
small
sirna
reduct
ph
gel
retard
assay
reveal
much
stabl
polyplex
success
silenc
use
much
lower
n
p
ratio
final
sinc
chitosan
modif
creat
steric
hindranc
reduc
chitosan
charg
densiti
usual
reli
reaction
amino
group
expect
reduc
chitosan
bind
affin
na
result
reduct
stabil
reveal
gel
retard
assay
studi
expect
reduct
observ
case
posit
charg
substitu
name
pei
use
discuss
chitosanna
polyplex
formul
vitro
transfect
prepar
use
excess
chitosan
vs
na
ie
n
p
ratio
one
use
asymmetr
flow
fieldflow
fraction
see
refer
detail
discuss
theori
coupl
uv
spectroscopi
light
scatter
determin
signific
proport
chitosan
unbound
polyplex
dispers
form
use
n
p
mix
ratio
techniqu
offer
advantag
provid
three
import
physicochem
properti
polyplex
name
proport
free
chitosan
polyplex
hydrodynam
size
size
distribut
second
studi
influenc
n
p
mix
ratio
examin
shown
polyplex
stoichiometri
ie
n
p
ratio
within
polyplex
rang
equival
free
chitosan
rang
polyplex
prepar
use
n
p
mix
ratio
rang
orang
ii
dye
deplet
method
constitut
rel
simpl
mean
evalu
proport
unbound
chitosan
polyplex
suspens
confirm
result
worth
mention
sinc
calcul
amount
bound
chitosan
reli
determin
free
chitosan
orang
ii
method
accuraci
calcul
decreas
somewhat
mix
n
p
ratio
increas
presenc
unbound
chitosan
requir
effici
transfect
cell
vitro
topic
discuss
detail
section
howev
despit
requir
signific
fraction
unbound
polyc
chitosanna
polyplex
formul
even
chitosan
recogn
nontox
use
high
n
p
valu
report
studi
rais
concern
possibl
side
effect
offtarget
effect
formul
consist
mostli
unbound
chitosan
propos
pei
transfect
effici
lie
high
buffer
capac
endosom
ph
rang
mediat
escap
endosom
protonspong
effect
propos
endolysosom
escap
mechan
acidif
endosom
lysosom
addit
pump
proton
endosom
along
concurr
influx
chlorid
ion
maintain
charg
neutral
caus
increas
osmot
pressur
vesicl
ruptur
direct
membran
perturb
mechan
swell
process
order
elucid
transfect
mechan
chitosanbas
polyplex
polyc
buffer
capac
measur
simpl
titrat
compar
pei
numer
studi
studi
conclud
chitosan
significantli
lower
buffer
capac
compar
pei
therefor
unlik
chitosan
could
escap
endosomelysosom
via
proton
spong
effect
howev
experi
led
conclus
chitosan
lower
buffer
capac
vs
pei
compar
buffer
capac
mass
concentr
basi
instead
molar
charg
concentr
basi
pei
mass
g
per
mol
ioniz
amin
time
charg
per
gram
chitosan
g
per
mol
ioniz
site
dda
polyelectrolyt
complex
pei
chitosan
form
chargetocharg
basi
n
p
particl
involv
endolysosom
escap
similar
charg
chitosan
pei
rather
similar
mass
account
unbound
compon
associ
particl
comparison
molar
charg
basi
reveal
chitosan
actual
larger
buffer
capac
pei
endosomallysosom
relev
ph
rang
implic
result
regard
transfect
mechan
chitosanna
polyplex
discuss
section
point
previous
one
drawback
chitosan
poor
solubl
neutral
ph
translat
colloid
unstabl
polyplex
physiolog
condit
colloid
stabil
polyplex
usual
assess
monitor
hydrodynam
size
vs
time
medium
mimick
physiolog
condit
eg
transfect
medium
pb
serum
mm
nacl
etc
size
chitosanna
polyplex
shown
increas
nm
micron
h
incub
pb
colloid
instabl
chitosanna
polyplex
physiolog
media
may
influenc
behavior
vivo
exampl
system
administr
via
intraven
inject
sever
chitosan
modif
propos
order
improv
solubl
polyplex
colloid
stabil
among
strategi
propos
pegyl
quatern
glycolyz
modif
shown
improv
chitosan
solubl
polyplex
colloid
stabil
vitro
extent
best
knowledg
apart
studi
lee
et
al
np
form
hydrophob
modifi
glycol
chitosan
shown
possess
rel
longcircul
time
colloid
stabil
circul
lifetim
modifi
polyplex
system
administr
intraven
inject
character
date
remain
seen
modif
appropri
applic
local
administr
suffici
howev
unlik
modif
chitosan
quatern
nt
reduc
shield
surfac
charg
order
limit
strong
interact
blood
compon
effici
increas
polyplex
colloid
stabil
circul
lifetim
vivo
pegyl
shown
increas
circul
lifetim
limit
aggreg
particl
therefor
promis
strategi
steric
shield
nanoparticl
blood
compon
increas
colloid
stabil
pegyl
chitosan
nanoparticl
surfac
report
studi
report
pegyl
chitosan
hydrophil
peg
graft
chitosan
backbon
prior
form
polyplex
presenc
bulki
substitu
could
limit
polyc
abil
complex
na
synthesi
chitosanpeg
block
copolym
pegbchitosan
anoth
avenu
yet
explor
could
potenti
circumv
issu
synthesi
could
achiev
via
reactiv
unit
new
reduc
chitosan
depolymer
nitrou
acid
develop
steric
stabil
chitosanna
formul
increas
colloid
stabil
circul
lifetim
would
highli
benefici
field
chitosanbas
gene
deliveri
system
aggreg
number
polyplex
measur
static
light
scatter
possibl
nta
polyplex
stoichiometri
known
sinc
nta
measur
particl
concentr
paramet
rare
measur
although
static
light
scatter
measur
polylysinepdna
polyplex
reveal
colloid
compact
pec
radiu
gyrat
smaller
nm
contain
pdna
copi
best
knowledg
aggreg
number
nt
measur
chitosanna
polyplex
character
chitosanna
polyplex
molecular
weight
function
formul
paramet
prepar
method
would
improv
understand
mechan
format
transfect
effici
te
refer
broadli
pdna
carrier
abil
induc
transgen
express
te
affect
multipl
experiment
paramet
robust
detect
assay
requir
determin
factor
influenc
transfect
traceabl
report
gene
gfp
luciferas
galactosidas
frequent
employ
varieti
gene
deliveri
strategi
fluoresc
transgen
gfp
allow
lysisfre
flow
cytometri
base
quantit
assess
gfp
galactosidas
enabl
qualit
measur
via
fluoresc
colorimetr
microscopi
cell
cultur
publish
measur
te
use
gfp
andor
luciferas
two
complementari
quantit
method
gfp
provid
percentag
cell
transient
express
transgen
luciferas
determin
level
transgen
express
date
multipl
method
analysi
data
present
te
render
comparison
one
studi
anoth
quit
challeng
gfpbase
paramet
percent
cell
posit
transgen
express
provid
good
refer
point
interstudi
comparison
use
alongsid
rel
light
unit
rlu
luciferas
sinc
rlu
vari
instrument
type
set
excitationemiss
filter
detector
gain
read
speed
provid
rel
express
level
rather
absolut
luciferas
concentr
absolut
luciferas
express
quantif
obtain
standard
purifi
luciferas
quantilum
recombin
luciferas
cat
nb
promega
use
facilit
interstudi
comparison
luciferas
base
transgen
assess
without
gfp
establish
posit
control
lipofectamin
pei
addit
proper
neg
control
carrier
chitosan
alon
dna
sirna
alon
nontarget
sirna
use
import
facilit
data
interpret
comparison
literatur
first
studi
chitosan
carrier
pdna
rolland
et
al
reveal
effect
mn
high
mn
kda
result
higher
te
serum
express
level
less
lipofectamin
control
thu
similarli
low
compar
achiev
chitosan
sinc
commerci
avail
bulk
chitosan
typic
high
molecular
weight
kda
subsequ
studi
use
chitosan
mostli
high
mn
type
without
depolymer
often
without
appropri
character
mn
dda
would
requir
understand
influenc
carrier
perform
te
latter
studi
still
gener
low
studi
nonetheless
constitut
foundat
chitosanbas
transfect
creat
impetu
optim
system
numer
method
depolymer
chitosan
subsequ
develop
review
nitrou
acid
depolymer
favor
techniqu
allow
reliabl
structurefunct
screen
account
mn
dda
screen
gener
contradict
rolland
et
al
origin
work
suggest
lower
mn
b
kda
chitosan
increas
te
compar
higher
mn
sinc
dda
second
primari
structur
paramet
chitosan
along
mn
studi
also
examin
influenc
te
suggest
higher
dda
n
effici
except
studi
use
larg
kda
chitosan
suggest
lower
dda
facilit
releas
dna
two
critic
paramet
mn
dda
screen
high
dda
low
mn
rang
accur
prepar
character
techniqu
sec
mal
mn
nmr
dda
enabl
thorough
structurebiolog
perform
screen
systemat
screen
reveal
signific
coupl
mn
dda
determin
te
therebi
establish
ration
structurefunct
relationship
mn
dda
modul
bind
affin
chitosan
pdna
obtain
fine
intermedi
balanc
high
low
affin
dna
produc
effici
transfect
level
similar
lipofectamin
fugen
physicochem
studi
subsequ
confirm
chitosan
high
te
fact
possess
intermedi
bind
affin
pioneer
studi
resolv
mani
inconsist
literatur
concern
effect
chitosan
system
gene
transfer
via
precis
account
effect
mn
dda
identif
central
import
intermedi
bind
affin
lead
effici
system
vitro
exampl
chitosan
high
dda
low
mn
kda
found
effici
simpli
increas
mn
kda
result
reduct
te
creat
tightli
bound
polyplex
simpli
reduc
dda
therebi
reduc
linear
charg
densiti
chitosan
constant
mn
kda
recov
lost
te
lead
similar
effici
ddamn
chitosan
result
highlight
need
precis
prepar
character
chitosan
gene
deliveri
vehicl
use
method
describ
section
addit
fine
control
mn
dda
optim
te
tailor
chitosan
cocomplex
algin
recent
substitut
trisaccharid
selfbranch
also
affect
bind
affin
improv
transfect
silenc
effici
although
mn
dda
still
import
paramet
affect
sirna
silenc
perform
seem
small
size
oligonucleotid
make
less
suscept
chang
chitosan
mn
dda
holzerni
et
al
found
np
chitosan
mn
perform
equal
well
dda
rang
mn
result
lower
silenc
use
itc
signific
differ
bind
affin
chitosan
sirna
found
moreov
malmo
et
al
report
similar
effici
mn
rang
kda
dpn
fulli
deacetyl
chitosan
interestingli
use
condit
similar
holzerni
serum
ph
differ
cell
type
hek
vs
human
lung
epitheli
cell
shown
optim
silenc
smaller
deacetyl
chitosan
first
glanc
recal
similar
relationship
chitosan
oligonucleotid
bind
affin
effici
plasmid
data
holzerni
et
al
malmo
et
al
combin
preliminari
data
lab
show
effect
silenc
effici
chitosan
increas
mn
dda
suggest
threshold
suffici
condens
achiev
increas
either
dda
mn
affect
perform
possibl
small
size
sirna
ca
nt
strongli
bound
highli
stabil
chitosan
architectur
compar
plasmid
thorough
screen
chitosanssirna
formul
mn
dda
similar
lavertu
et
al
plasmid
would
provid
complet
understand
chitosansirna
polyplex
serum
high
transfect
effici
chitosan
serum
key
advantag
compar
nonvir
vector
sinc
vitro
studi
perform
condit
physiolog
relev
clinic
translat
transfect
serum
also
indirectli
assess
polyplex
stabil
posit
uptak
te
impli
nucleas
protect
cargo
polynucleotid
earli
studi
quick
point
advantag
chitosan
nonvir
vector
pei
liposom
erbach
et
al
first
find
inhibitori
effect
serum
chitosan
subsequ
studi
mostli
underscor
serum
enhanc
efficaci
chitosanbas
polyplex
despit
observ
ad
valu
use
serum
recent
studi
use
glycosyl
chitosan
use
serum
prefer
optimem
serum
free
even
prior
studi
demonstr
serum
compat
glycosyl
chitosan
similar
transfect
linear
chitosan
subsequ
studi
sirna
group
conduct
serumfre
media
still
entir
clear
serum
increas
te
chitosan
suggest
better
cell
function
includ
cell
divis
endocytosi
nimesh
et
al
shown
level
polyplex
uptak
ph
upregul
presenc
serum
first
h
correspond
increas
luciferas
level
increas
uptak
serum
shown
even
accentu
chitosan
possibl
due
format
condens
particl
chitosan
serum
protein
thu
increas
uptak
free
fraction
chitosan
n
p
serum
addit
might
facilit
endosom
releas
character
near
physiolog
condit
would
allow
better
estim
type
polyplex
actual
present
cell
vitro
gain
understand
serummedi
effect
howev
measur
method
nanos
particl
difficult
biolog
media
prone
signific
background
signal
therefor
analys
often
overlook
develop
new
vector
one
potenti
futur
avenu
follow
improv
polyplex
size
measur
serum
nanoparticl
track
method
singl
particl
track
flow
cytometrybas
size
determin
shown
promis
size
measur
nanocomplex
serum
techniqu
could
improv
predict
valu
physicochem
size
character
vitro
vivo
effici
chitosanbas
polyplex
ph
cation
charg
densiti
chitosan
phdepend
low
charg
densiti
physiolog
ph
lead
low
solubl
aggreg
poor
stabil
chitosanbas
formul
henc
polyplex
prepar
usual
made
acid
condit
optim
complex
dna
provid
colloid
stabil
addit
cell
cultur
impos
near
physiolog
ph
ionic
strength
evalu
literatur
reveal
ph
frequent
use
success
attribut
primarili
posit
zeta
potenti
favor
cell
contact
interparticl
electrostat
repuls
colloid
stabil
optim
physic
stabil
polyplex
provid
protect
nucleas
serum
transfect
media
nimesh
et
al
show
strong
correl
uptak
te
ph
uptak
te
subsequ
increas
decreas
ph
size
measur
show
increas
size
ph
ionic
strength
indic
aggreg
higher
ph
correl
microscopi
imag
support
previou
observ
aggreg
neutral
ph
isoosmolar
condit
circumv
problem
mani
type
chitosan
deriv
synthes
goal
improv
solubl
result
colloid
stabil
polyplex
physiolog
media
includ
pegyl
glycosyl
trimethyl
modifi
chitosan
shown
improv
dna
protect
te
vitro
physiolog
ph
motiv
vivo
studi
ascertain
advantag
chitosan
n
p
ratio
review
section
certain
level
n
p
ratio
determin
stoichiometri
polyplex
affect
colloid
physic
stabil
especi
high
ionic
strength
media
mumper
first
provid
evid
import
n
p
achiev
stabil
te
follow
other
establish
polycationbas
gene
deliveri
effici
n
p
ratio
chitosan
gene
express
usual
involv
n
p
ratio
least
sometim
signific
amount
excess
polyc
remain
free
solubl
solut
without
physic
bound
chitosandna
polyplex
effici
n
p
ratio
excess
polyc
alway
empir
identifi
mean
excess
polyc
improv
te
identifi
recent
recent
studi
reveal
first
time
mechan
excess
free
polyc
induc
effici
transfect
mainli
involv
promot
releas
chitosandna
polyplex
lysosom
cytoplasm
import
step
nucleotid
deliveri
discuss
find
also
partli
explain
surprisingli
high
n
p
ratio
use
studi
chitosansirna
deliveri
rang
contrast
other
shown
good
silenc
n
p
ratio
n
p
malmo
et
al
found
fulli
deacetyl
chitosan
low
mn
kda
requir
n
p
effici
silenc
higher
mn
test
ratio
perform
equal
silenc
ph
serumfre
media
highlight
stabil
effect
increas
n
p
ph
serum
shown
perform
best
silenc
n
p
similar
holzerni
et
al
chitosan
discrep
among
studi
make
overal
comparison
difficult
opinion
extrem
high
n
p
ratio
limit
dosag
nucleotid
difficult
translat
clinic
applic
chitosan
often
describ
biodegrad
nontox
safe
fda
approv
chitosanbas
wound
dress
biomateri
biodegrad
chitosan
number
physiolog
enzym
present
human
lysozym
dinacetylchitobias
nacetylbetadglucosaminidas
chitiotriosidas
well
document
perhap
reason
cytotox
effect
chitosan
focu
studi
either
gene
drug
deliveri
yet
studi
report
slow
degrad
chitosan
high
dda
could
therefor
present
risk
accumul
tissu
long
period
administr
lower
biodegrad
concur
huang
et
al
find
increas
cytotox
polyplex
prepar
increas
dda
recent
review
chitosan
broad
use
nanomedicin
kean
et
al
garciafuent
et
al
also
argu
toxic
appear
increas
charg
densiti
high
dda
toxic
becom
mndepend
studi
trend
observ
polynucleotid
deliveri
howev
toxic
high
dda
compound
high
mn
follow
gener
observ
lab
decreas
cell
densiti
round
morpholog
high
degre
deacetyl
charg
densiti
near
dda
could
impli
cytotox
cytostat
effect
howev
extens
cell
viabil
cytotox
test
yet
perform
chitosan
type
date
provid
evid
dda
kda
mn
nontox
cytotox
high
dda
chitosan
also
found
dosedepend
human
intestin
epitheli
cell
garciafuent
cite
ic
mgml
cell
model
vari
dda
mn
moreov
describ
chitosan
macrophag
activ
guzmanmoral
et
al
show
chitosan
concentr
attract
macrophag
directli
activ
marrowderiv
macrophag
toward
either
altern
classic
pathway
rather
neutrophil
yet
determin
cascad
interestingli
group
varum
strand
et
al
consist
work
fulli
deacetyl
chitosan
advers
effect
cell
health
accord
mtt
alamar
blue
sirna
studi
judici
mix
mtt
lactat
dehydrogenas
leakag
assay
ldh
note
assay
whose
detect
reli
live
cell
mtt
base
dehydrogenas
activ
healthi
mitochondria
superior
sensit
ldh
detect
cell
death
strand
et
al
argu
low
mn
oligom
increas
solubil
normal
ph
particularli
glycosyl
help
prevent
cytotox
often
associ
high
charg
densiti
acid
ph
high
dda
high
mn
acid
ph
lower
toxic
low
mn
kda
dda
report
elsewher
well
short
h
incub
time
polyplex
might
also
limit
cytotox
particularli
fulli
deacetyl
chitosan
chain
mn
sirna
mtt
perform
h
posttransfect
h
ldh
halflif
leak
ldh
report
around
h
manufactur
despit
high
number
publish
report
patent
highlight
potenti
chitosan
nanomedicin
chitosan
yet
approv
fda
drug
gene
deliveri
incomplet
cytotox
profil
possibl
account
slow
translat
progress
even
larg
cytotox
chitosan
insignific
compar
synthet
vector
proper
thorough
cytotox
effect
screen
relat
structur
charg
densiti
cell
relev
applic
includ
primari
cell
conduct
addit
vivo
translat
clinic
applic
particularli
applic
requir
iv
administr
proxim
cell
polynucleotid
deliveri
system
need
overcom
sever
obstacl
achiev
express
includ
cell
bind
intern
escap
endolysosom
vesicl
polyplex
unpackingdissoci
plasmid
dna
nuclear
transloc
one
limit
studi
investig
chitosanpolynucleotid
deliveri
system
reli
entir
endpoint
quantif
report
gene
express
assess
efficaci
potenti
formul
improv
inform
approach
studi
transfect
mechan
result
effici
carrier
track
intracellular
process
microscopi
use
fluoresc
label
na
carrier
order
observ
potenti
quantifi
interact
compon
cell
substructur
major
barrier
approach
significantli
contribut
ration
design
genecarri
natur
relationship
cellular
uptak
physicochem
properti
chitosan
recent
review
effect
intracellular
extracellular
environ
well
particl
size
shape
surfac
charg
characterist
uptak
discuss
detail
brief
earli
studi
found
strong
correl
uptak
size
howev
presenc
serum
acid
ph
size
measur
dl
shown
exert
littl
influenc
uptak
consist
rolland
origin
work
show
particl
size
influenc
transgen
express
serum
present
correl
size
measur
dl
te
complex
media
still
clear
especi
serum
neg
charg
protein
known
chang
morpholog
polyplex
sometim
form
protein
corona
well
caus
aggreg
uptak
shown
mani
cell
line
bottleneck
studi
shown
variat
uptak
chitosan
formul
necessarili
translat
variat
te
intern
polyplex
import
barrier
still
must
overcom
especi
true
particl
stabl
effect
intracellular
dissoci
particl
usual
posit
zeta
potenti
bind
neg
charg
cell
membran
easili
intern
evid
cell
membran
bind
permeat
precondit
transfect
attain
certain
level
shown
lysosom
escap
unpack
dna
chitosan
carrier
may
even
import
factor
determin
transfect
effici
polyplex
chitosan
te
celllin
depend
mani
demonstr
high
transfect
effici
establish
cell
line
hek
moder
te
observ
challeng
cell
line
hela
mdck
cell
chitosanpei
graft
shown
increas
transfect
hela
cell
uptak
assess
celllin
depend
te
attribut
variat
membran
phenotyp
type
receptor
variat
activ
endocyt
pathway
cell
type
instanc
dougla
et
al
show
cell
line
depend
te
mainli
due
prefer
endocyt
pathway
chitosan
polyplex
intern
level
uptak
per
se
studi
cell
favor
clathrin
mediat
pathway
promot
transfect
oppos
cho
cell
prefer
caveolin
mediat
endocytosi
reason
still
unclear
te
challeng
even
pronounc
primari
cell
gener
quiescent
cell
line
divid
within
h
cell
divis
facilit
access
transgen
nucleu
quiescent
cell
activ
nuclear
transloc
via
nuclear
pore
essenti
even
primari
divid
cell
type
mesenchym
stem
cell
earli
attempt
transfect
prove
unsuccess
screen
variou
cell
line
well
nondivid
cell
would
improv
predict
valu
vitro
test
transit
endocytos
endosom
acidif
pathway
lead
lysosom
often
regard
major
barrier
nonvir
base
gene
transfer
compar
pei
studi
examin
traffick
chitosan
polyplex
endolysosom
pathway
studi
exclus
use
lysotrack
lysosom
stain
assess
coloc
polyplex
track
intracellular
distribut
appear
suggest
chitosan
polyplex
transit
lysosom
short
period
within
h
transfect
suggest
direct
contradict
recent
studi
use
pulsechas
fluoresc
dextran
lysosom
stain
reveal
chitosanbas
polyplex
independ
structur
transit
lysosom
nearli
coloc
h
h
posttransfect
h
incub
time
follow
gradual
releas
h
moment
transfect
peak
lack
consensu
studi
could
stem
part
use
differ
methodolog
transfect
lysosom
stain
includ
differ
cell
type
transfect
ph
use
acidophil
lysotrack
dye
versu
dextran
context
import
note
inhibit
lysosom
acidif
abolish
lysotrack
fluoresc
acidophil
partit
therefor
agent
may
accur
marker
lysosom
load
polyc
endow
proton
buffer
capac
pei
chitosan
prevent
lysosom
acidif
note
elsewher
use
electron
microscopi
lysosom
sequestr
appear
account
later
onset
gene
express
compar
polyc
pei
vesicular
escap
observ
within
first
h
transfect
signific
gene
express
detect
earli
h
posttransfect
thu
lysosom
sequestr
rate
limit
step
chitosan
carrier
independ
chitosan
mn
dda
delay
gene
express
current
observ
possibl
attain
number
transfect
cell
cell
speed
high
effect
polym
pei
gener
attribut
abil
rapidli
escap
endolysosom
mean
high
buffer
capac
mechan
known
proton
spong
effect
first
describ
behr
group
follow
observ
lysosomotrop
agent
chloroquin
increas
te
pei
proton
spong
hypothesi
describ
abil
polyc
swell
ruptur
vesicl
rais
intravesicular
osmot
pressur
proton
buffer
coupl
concomit
influx
neg
charg
ion
cl
studi
compar
pei
chitosan
buffer
capac
suggest
pei
possess
higher
buffer
capac
broader
ph
interv
chitosan
determin
acidbas
titrat
reason
combin
slow
transfect
kinet
note
endosom
escap
mechan
chitosan
system
usual
attribut
either
direct
hydrostat
membran
destabil
rise
vesicular
osmolar
lysosom
enzymeinduc
degrad
product
polyc
although
neither
hypothesi
support
data
howev
mention
section
richard
et
al
recent
address
technic
flaw
found
literatur
name
comparison
buffer
capac
chitosan
versu
pei
perform
mass
basi
without
account
ratio
proton
site
mass
richard
et
al
recent
found
chitosan
buffer
capac
superior
pei
equival
charg
ratio
ph
relev
vesicular
traffick
find
agreement
gener
absenc
benefici
effect
complet
prevent
endosom
fusion
lysosom
henc
inhibit
lysosom
transit
polyplex
occur
chloroquin
ad
start
transfect
similar
found
pei
reason
chitosan
long
lysosom
transit
time
compar
pei
remain
determin
could
due
lower
linear
charg
densiti
weaker
membran
disrupt
abil
chitosan
effect
worth
mention
import
valid
proton
spong
hypothesi
induc
escap
improv
te
challeng
also
complex
polynucleotid
proton
amin
chitosan
becom
ioniz
possibl
reduc
buffer
capac
latter
may
also
account
slower
tabl
select
studi
use
chitosanbas
pdna
nanoparticl
gene
deliveri
anim
model
burn
injur
nanoparticl
use
lead
higher
express
vegf
alphasma
protein
involv
angiogenesi
dermal
regener
lewi
rat
aia
rat
model
osteosarcoma
ppedf
microparticl
treatment
result
decreas
primari
tumor
growth
reduct
bone
lysi
reduct
lung
metastas
balbc
mice
mannosyl
chitosan
intratumor
cancer
complex
enhanc
product
therebi
suppress
tumor
growth
icr
mice
chitosan
kda
oral
lacz
gene
erythropoietin
anemia
mice
fed
chitosanmepo
nanoparticl
show
rapid
enhanc
hematocrit
went
second
administr
mice
nacetyl
chitosan
mw
dda
oral
lacz
gene
vaccin
gastrointestin
diseas
effect
transgen
deliveri
gastrointestin
track
transfect
kinet
highlight
import
role
excess
dnafre
chitosan
promot
releas
vitro
view
chitosan
may
also
benefit
intravesicular
degrad
increas
osmolar
possibl
necessit
longer
process
time
insid
lysosom
hand
pei
higher
charg
densiti
might
less
mask
bind
polynucleotid
may
activ
destabil
vesicular
membran
cytotox
partli
blame
despit
slow
transit
kinet
chitosanna
polyplex
reason
buffer
capac
chitosan
mix
function
buffer
moieti
attempt
increas
te
mix
pei
polypropyl
acryl
acid
graft
pei
histidin
imidazolecontain
compon
constitut
recent
strategi
overcom
endolysosom
barrier
time
intracellular
dna
unpack
releas
anoth
import
ratelimit
step
chitosan
condens
polyc
gener
despit
import
coupl
mn
dda
toward
optim
bind
high
transfect
effici
studi
assess
structur
paramet
chitosan
influenc
state
polyplex
condens
insid
cell
particl
stabil
difficult
monitor
intracellularli
part
pertain
distanc
nm
resolut
limit
light
microscop
nm
techniqu
fluoresc
reson
energi
transfer
fret
import
tool
monitor
condens
state
polyplex
intracellularli
first
studi
use
fret
assess
polyplex
stabil
mostli
compar
one
chitosan
type
polyc
without
account
strong
influenc
dda
mn
transfect
process
quantum
dot
use
effici
flexibl
fret
studi
provid
cue
dissoci
import
factor
te
howev
qdchitosan
complex
shown
te
nearli
complet
abolish
possibl
due
size
qd
label
follow
chitosan
differ
formul
use
organ
dye
rhodamin
b
donor
chitosan
acceptor
pdna
reveal
kinet
polyplex
unpack
decondens
critic
formulationdepend
intracellular
process
could
account
import
relationship
te
chitosan
structur
valid
first
time
ddamn
coupl
effect
optim
bind
result
finebal
exact
mechan
promot
dissoci
selfassembl
polyplex
yet
understood
mani
suggest
competit
cytoplasm
polyanion
includ
protein
rna
case
partial
degrad
enzymelabil
biodegrad
chitosan
lysosom
may
facilit
downstream
cytoplasm
decomplex
coincub
chitosanas
suggest
potenti
lysosomalinduc
degrad
escap
increas
te
condens
polyplex
import
dissoci
also
evidenc
addit
labil
bond
chitosan
attempt
facilit
intracellular
decomplex
increas
te
best
knowledg
studi
date
examin
tool
fret
livecel
lysosom
stain
intracellular
dissoci
dynam
lysosom
coloc
respect
chitosansirna
polyplex
viral
vector
proven
effici
gene
deliveri
howev
clinic
applic
limit
due
safeti
risk
unexpect
advers
effect
contrast
nonvir
vector
liposom
polyc
complex
increasingli
develop
recent
year
low
immunogen
eas
product
modif
control
condit
need
effect
humor
cellular
respons
induc
genet
immun
requir
deliveri
vehicl
lead
improv
present
transgen
product
antigenpres
cell
apc
chitosan
packag
dna
improv
cell
uptak
adhes
biomateri
extend
period
contact
activ
agent
target
cell
tissu
also
chitosan
innat
abil
open
tight
junction
cell
therebi
increas
uptak
carri
agent
cell
increas
membran
permeabl
choic
adequ
rout
administr
dna
vaccin
import
decis
toward
clinic
applic
administr
directli
target
tissu
system
deliveri
potenti
transfect
appropri
cell
type
vivo
abl
elicit
subsequ
immun
dna
encod
antigen
key
success
induc
immun
encod
protein
must
present
surfac
appropri
cell
respond
b
cell
present
take
place
transfect
somat
cell
eg
myocyt
fibroblast
apc
lead
uptak
express
antigen
profession
apc
present
crossprim
pathway
rout
mucos
vaccin
oral
intranas
common
rout
pathogen
entri
bodi
prefer
gener
local
immun
protect
addit
system
immun
respons
roy
et
al
use
chitosanpdna
nanoparticl
nm
size
oral
immun
domin
peanut
allergen
gene
immun
mice
show
substanti
reduct
allergeninduc
anaphylaxi
associ
reduc
level
ige
plasma
histamin
vascular
leakag
also
immun
mice
produc
secretori
iga
plasma
prove
chitosanpdna
nanoparticl
reach
target
mucosalassoci
lymphoid
tissu
peyer
patch
gut
respiratori
tract
cell
presenc
apc
macrophag
process
recombin
antigen
lead
activ
cell
b
cell
see
tabl
summari
oral
vaccin
studi
intranas
administr
chitosanpdna
nanoparticl
second
princip
rout
mucos
immun
sever
author
specul
chitosanpdna
nanoparticl
may
pass
mucos
membran
directli
transfect
apc
taken
first
celllik
cell
oral
administr
nasal
associ
lymphoid
tissu
present
apc
khatri
et
al
use
intranas
administr
chitosan
dda
kda
mn
pdna
nanoparticl
express
surfac
antigen
hepat
b
viru
hbsag
immun
hepat
b
balbc
mice
model
show
success
gener
system
immun
respons
humor
cellular
spheric
chitosanpdna
nanoparticl
diamet
nm
abl
elicit
system
immun
respons
igg
level
antihbsag
clinic
protect
level
miuml
addit
intranas
vaccin
elicit
mucos
immun
respons
product
iga
secretori
antibodi
see
tabl
summari
intranas
vaccin
studi
system
vaccin
rout
chitosanpdna
base
vaccin
intraven
intramuscular
subcutan
intraperiton
consid
target
apc
macrophag
howev
comparison
dna
vaccin
nanocarri
fewer
conclus
studi
perform
date
chitosanpdna
nanoparticl
system
vaccin
jean
et
al
show
inject
balbc
mice
chitosanpdna
express
human
pdgfbb
nanoparticl
subcutan
sc
rout
led
enhanc
level
antigenspecif
antibodi
antipdgfbb
compar
intramuscular
im
inject
interestingli
specif
immun
respons
obtain
depend
intim
specif
chitosan
use
complex
agent
pdna
lower
dda
higher
mn
kda
chitosan
induc
highest
level
antigenspecif
antibodi
associ
sustain
influx
host
cell
associ
degrad
chitosan
sc
im
rout
administr
produc
respons
act
differ
manner
term
rais
specif
antibodi
preval
apc
differ
muscl
sc
tissu
like
network
apc
resid
target
tissu
act
decisionmak
extent
humor
respons
versu
accumul
recombin
protein
elicit
two
administr
rout
chitosanpdna
express
vector
differ
amplitud
qualiti
immun
respons
suggest
apc
transfect
im
sc
locat
function
distinct
therefor
prime
immun
respons
uniqu
follow
im
inject
dna
taken
myocyt
howev
myocyt
normal
express
mhc
ii
costimulatori
molecul
prime
cell
henc
need
apcmacrophag
intervent
howev
apc
transfect
may
present
sc
inject
demonstr
intraderm
dna
inject
studi
examin
immun
modul
respons
chitosan
provid
variabl
result
possibl
due
differ
chitosan
type
mn
dda
prepar
method
use
studi
addit
recombin
product
detect
inject
site
surround
tissu
sever
week
administr
broken
rapidli
permit
apc
macrophag
process
antigen
eventu
activ
b
cell
cell
known
transfect
effici
chitosanbas
nanoparticl
depend
sever
factor
chemic
structur
specif
chitosan
dda
mn
chitosan
modif
size
charg
composit
polyplex
includ
type
form
size
dnarna
cargo
interact
polyplex
cell
endocytosi
pinocytosi
cytoplasm
traffick
cross
nuclear
pore
complex
cell
type
number
studi
show
success
deliveri
recombin
dna
sustain
transgen
express
local
system
target
site
perform
anim
model
myriad
chitosan
paramet
dda
mn
np
ratio
nanoparticl
size
intrins
extrins
modif
tabl
among
studi
effect
oral
deliveri
chitosan
dda
kda
mn
therapeut
gene
carrier
demonstr
bowman
et
al
success
induc
factor
viii
synthesi
variou
organ
hemophilia
murin
model
fviii
exon
knockout
mice
transgen
dna
detect
local
system
tissu
result
one
month
hemophilia
phenotyp
correl
mice
treat
chitosanpdna
fviii
dna
nanoparticl
compar
mice
treat
nake
fviii
plasmid
dna
untreat
mice
howev
explan
offer
presenc
chitosanpdna
nanoparticl
liver
spleen
mechan
transport
intestin
lumen
hepat
circul
success
chitosan
gene
carrier
corrobor
jean
et
al
use
low
molecular
weight
chitosan
dda
dda
kda
mn
deliv
intramuscularli
subcutan
recombin
plasmid
express
glucagonlik
peptid
control
type
diabet
zucker
diabet
fatti
zdf
rat
model
anim
treat
saw
increas
plasma
concentr
level
insulin
associ
normal
blood
glucos
persist
day
last
inject
compar
half
life
sever
minut
inject
peptid
also
klausner
et
al
demonstr
inject
stroma
rat
cornea
formul
oligomer
chitosanpdna
dda
kda
mn
express
luciferas
green
fluoresc
protein
gfp
led
gene
express
greater
inject
peipdna
nanoparticl
chitosan
chitosan
deriv
formul
increasingli
studi
recent
deliveri
therapeut
protein
express
plasmid
anim
model
varieti
applic
includ
cancer
diabet
anemia
hemophilia
osteosarcoma
arthriti
corneal
diseas
burn
injuri
use
intratumor
intraven
oral
intramuscular
subcutan
intraperiton
intratrach
intrastroma
topic
rout
administr
summari
studi
provid
tabl
rna
interfer
rnai
innat
mechan
wherebi
small
doublestrand
rna
dsrna
lead
sequencespecif
gene
silenc
rnai
provid
potenti
new
class
therapeut
effect
mammalian
cell
reach
clinic
trial
howev
direct
deliveri
sirna
achiev
rnai
continu
problemat
owe
rapid
extraintracellular
degrad
ubiquit
nucleas
limit
blood
stabil
poor
cellular
uptak
well
offtarget
effect
despit
progress
achiev
chemic
modif
increas
sirna
halflif
transfect
effici
cellular
target
uptak
remain
obstacl
effect
deliveri
therefor
packag
system
transport
protect
ubiquit
nucleas
chemic
unmodifiedmodifi
sirna
target
cell
requir
chitosan
increasingli
studi
sirna
deliveri
anim
model
field
cancer
bone
repair
rheumatoid
arthriti
inflammatori
diseas
infecti
diseas
tabl
field
cancer
import
propos
applic
gene
therapi
salva
et
al
target
vascular
endotheli
growth
factor
gene
vegf
rat
breast
cancer
model
found
chitosan
kda
dda
vegf
sirna
nanocomplex
remark
suppress
effect
vegf
express
tumor
volum
han
et
al
target
transglutaminas
gene
melanoma
breast
cancer
bear
nude
mice
demonstr
chitosan
hydrogel
nanocomplex
chhg
dda
kda
deliv
intratumor
permit
higher
local
sirna
tumor
incorpor
sirna
chhg
inde
requir
effect
deliveri
target
modul
decreas
tumor
cell
prolifer
angiogenesi
increas
tumor
cell
apoptosi
observ
kim
et
al
ovarian
carcinoma
nude
mous
model
follow
intraven
administr
chitosantppsirna
silenc
scr
fgr
famili
kinas
twice
week
dose
lee
et
al
administ
polysirnaglycol
chitosan
nanoparticl
psitgc
target
vegf
specif
sirna
intraven
prostat
cancer
xenograft
murin
model
found
chitosan
nanoparticl
provid
suffici
vivo
stabil
system
deliveri
sirna
result
knockdown
vegfspecif
mrna
associ
reduct
tumor
size
vascular
indic
inhibit
angiogenesi
origin
vegfspecif
gene
silenc
howard
et
al
downregul
express
rheumatoid
arthriti
collageninduc
arthrit
cia
mice
model
intraperiton
administr
chitosan
dda
n
p
ratio
nanoparticl
found
downregul
inflammatori
respons
arrest
joint
swell
howev
despit
attempt
identifi
optim
physicochem
paramet
sirna
deliveri
inconclus
result
observ
literatur
due
experiment
discrep
exampl
report
intermedi
dda
high
mn
kda
chitosan
effici
low
mn
chitosan
kda
deliv
sirna
yet
high
mn
chitosan
found
cytotox
thu
potenti
limit
use
addit
report
evalu
physicochem
paramet
chitosansirna
nanoparticl
perform
high
n
p
ratio
n
p
n
formul
possess
signific
practic
problem
includ
limit
dose
due
aggreg
nonspecif
effect
larg
quantiti
solubl
chitosan
demonstr
maxim
vitro
transfect
effici
deliveri
pdna
depend
fine
balanc
tunabl
paramet
chitosan
maximum
transgen
tabl
studi
use
chitosanbas
sirna
nanoparticl
deliveri
system
gene
silenc
anim
model
author
use
plasmid
encod
rat
treat
prior
rsv
exposur
show
switch
phenotyp
reduct
cd
cell
therebi
lead
effect
lung
viral
clearanc
without
damag
airway
tissu
express
found
dda
mn
valu
run
along
diagon
high
ddalow
mn
low
ddahigh
mn
also
demonstr
specif
chitosan
formul
dda
mw
n
p
ratio
abl
effici
express
transgen
vivo
andor
trigger
antitransgen
immun
respons
therefor
chitosan
polynucleotid
nanoparticl
must
design
base
finetun
chitosan
paramet
applicationspecif
purpos
gene
therapi
genet
vaccin
extent
chitosan
biodegrad
depend
mn
dda
need
consid
new
chitosan
formul
propos
gene
therapi
along
fact
degrad
pathway
chitosan
chitosan
deriv
vivo
fulli
elucid
chitosan
degrad
vertebr
enzym
lysozym
bacteri
enzym
colon
hydrolyz
glucosamineglucosamin
glucosaminenacetylglucosamin
nacetylglucosaminenacetylglucosamin
linkag
richardson
et
al
follow
biodistribut
chitosan
rat
iv
inject
radioiodin
chitosan
differ
mn
dda
around
five
sixti
minut
administr
ilabel
chitosan
recov
organ
vari
significantli
major
found
blood
liver
lung
small
dose
found
spleen
kidney
thyroid
heart
specif
ilabel
chitosan
mn
n
kda
min
less
inject
fraction
recov
blood
alreadi
liver
chitosan
mn
b
kda
clear
circul
slowli
inject
fraction
present
blood
less
liver
min
postadministr
gao
et
al
show
chitosan
liposom
jetpei
base
formul
greatli
improv
stabil
biodistribut
sirna
howev
high
accumul
chitosanbas
sirna
nanocomplex
observ
within
kidney
h
postadministr
observ
confirm
lee
et
al
monitor
fluoresc
imag
biodistribut
multimer
polymer
sirna
glycol
chitosan
nanoparticl
psitgc
intraven
administr
prostat
tumor
xenograft
mice
signific
retent
chitosan
nanoparticl
kidney
day
postinject
may
origin
longer
blood
circul
time
compar
free
sirna
lee
et
al
suggest
retent
polysirnaglycol
chitosan
nanoparticl
psitgc
kidney
repres
health
risk
sinc
excret
bodi
via
kidney
take
place
sever
day
postinject
gao
et
al
suggest
nanoparticl
accumul
may
reflect
mucoadhes
chitosan
mucos
epithelium
line
kidney
could
exploit
sirnabas
treatment
renal
diseas
yan
et
al
evalu
pharmacokinet
profil
nsuccinylchitosan
nanoparticl
without
na
tail
vein
inject
rat
demonstr
nanoparticl
accumul
mainli
tumor
gao
et
al
mao
et
al
show
accumul
kidney
chitosansirna
chitosanpdna
nanoparticl
timedepend
biodistribut
studi
also
perform
huh
et
al
sirnaglycol
chitosanpei
nanoparticl
use
cancer
bear
mice
inject
intraven
nanoparticl
show
strong
fluoresc
signal
tumor
tissu
within
h
inject
nanoparticl
preferenti
accumul
tumor
day
indic
higher
tumortarget
abil
support
work
lee
et
al
show
nanoparticl
could
preferenti
deliv
sirna
target
tumor
tissu
least
day
prolong
circul
time
polymer
nanoparticl
allow
extravas
accumul
tumor
tissu
due
disorgan
defect
vascular
architectur
tumor
effect
refer
enhanc
permeabl
retent
epr
effect
tumor
tissu
result
indic
stabil
nanoparticl
bloodstream
reach
tumor
support
group
torchilin
et
al
show
nanoparticl
size
rang
nm
accumul
effici
tumor
site
epr
effect
vivo
contrast
lee
et
al
show
tumorbear
mice
inject
polysirna
psipei
show
signific
increas
fluoresc
signal
tumor
site
first
day
postinject
psipei
found
liver
expect
among
excis
organ
tumor
tissu
psithiol
glycol
chitosan
tgc
treat
mice
show
strongest
fluoresc
signal
observ
nanoparticl
biodistribut
also
support
cheng
et
al
follow
intraven
inject
galactosyl
chitosanpdna
nanoparticl
express
mgmscf
transgen
anim
model
bear
colon
liver
tumor
express
level
transgen
increas
significantli
colon
cancer
liver
compar
spleen
kidney
lung
muscl
heart
despit
harsh
environ
gastrointestin
tract
effect
vivo
deliveri
pdna
clearli
demonstr
oral
administr
chitosanbas
nanoparticl
oral
administr
chitosan
chitosan
deriv
pdna
nanoparticl
led
effici
gene
transduct
intestin
epithelium
stomach
gastric
upper
intestin
mucosa
well
establish
chitosan
chitosan
deriv
depend
dda
mn
abl
protect
complex
na
nucleas
degrad
chitosan
chitosan
deriv
posit
charg
gastric
duoden
ph
neutral
intestin
alkalin
ph
abl
increas
transand
paracellular
intestin
permeabl
gene
express
may
trigger
solubilitydegrad
chitosanbas
nanocomplex
acid
ph
environ
andor
microflora
colon
kai
ochiya
use
chitosan
alon
dda
mw
nacetyl
chitosan
deliv
gal
report
gene
intestin
oral
administr
confirm
gene
express
chitosan
duodenum
jejunum
ileum
colon
day
postadministr
bowman
et
al
use
chitosan
dda
factor
viii
pdna
nanoparticl
mix
gelatin
oral
administr
fviii
exon
knockout
mice
show
presenc
plasmid
dna
peyer
patch
also
stomach
ileum
liver
spleen
h
postadministr
find
plasmid
dna
nongastrointestin
tissu
indic
pdna
abl
cross
intestin
barrier
reach
either
blood
lymph
circul
noteworthi
plasmid
biodistribut
determin
qualit
assay
confirm
realtim
pcr
none
realtim
pcr
result
achiev
statist
signific
due
high
variabl
zheng
et
al
use
quatern
chitosantrimethyl
chitosan
oligom
dda
kda
mw
plasmid
dna
express
gfp
report
oral
feed
nude
mice
show
gfp
express
stomach
duodenum
jejunum
ileum
larg
intestin
date
investig
relat
timedepend
biodistribut
oral
administr
nanoparticl
perform
tian
et
al
encapsul
pdna
encod
major
capsid
protein
mcp
lcd
viru
gfp
chitosan
dda
kda
mw
microspher
emulsionbas
methodolog
oral
vaccin
fish
detect
mcp
recombin
mrna
gill
intestin
spleen
kidney
day
postvaccin
result
confirm
signific
enhanc
green
fluoresc
protein
product
tissu
day
postvaccin
intranas
administr
chitosanbas
pdnasirna
nanoparticl
mainli
nasal
vaccin
target
nasalassoci
lymphoid
tissu
pharynx
biodistribut
chitosansirna
nanoparticl
follow
intranas
intratrach
administr
studi
egfptransgen
mice
monitor
egfp
gene
silenc
chitosan
dda
kda
mn
sirnaegfp
nanoparticl
administr
intranas
period
achiev
reduct
egfp
express
bronchiolar
epithelia
lower
upper
region
mous
lung
moreov
higher
egfp
gene
silenc
achiev
bronchial
epitheli
cell
transgen
mice
use
guanidinyl
chitosan
gfpsirna
salbutamol
modifi
guanidinyl
chitosan
gfpsirna
nanoparticl
instead
unmodifi
chitosan
dda
kda
mn
gfpsirna
nanoparticl
similar
result
obtain
kong
et
al
intranas
administr
high
mn
chitosanbas
nanoparticl
deliv
plasmid
dna
encod
control
viral
load
rsv
infect
mice
lung
hiang
et
al
succeed
deliv
aerosol
plasmid
dna
produc
shrna
complex
folatechitosangraftpei
specif
silenc
kinas
target
lung
tumor
cell
csaba
et
al
show
intratrach
administr
low
mn
pentasodium
tripolyphosph
chitosan
cstpp
pcmvxgal
nanoparticl
load
pcmvxgal
mediat
strong
gene
express
mous
lung
h
postadministr
contrast
high
mn
cs
tpp
nanoparticl
nake
pdna
howev
kopinghoggard
et
al
monitor
luciferas
express
mous
lung
h
intratrach
administr
nanoparticl
found
increas
luciferas
gene
express
low
mn
compar
high
mn
chitosan
later
group
found
luciferas
express
mous
lung
higher
trisaccharidesubstitut
chitosan
oligom
correspond
linear
chitosan
oligom
result
emphas
import
use
welldefin
low
mn
nanoparticl
intratrach
rout
administr
fewer
studi
address
biodistrut
chitosanbas
pdna
sirna
nanoparticl
follow
intramuscular
subcutan
administr
jean
et
al
use
differ
chitosan
formul
deliv
im
sc
plasmid
dna
encod
pdgfbb
recombin
protein
show
effici
express
transgen
muscl
cell
surround
tissu
addit
recombin
protein
level
balbc
mice
muscl
significantli
higher
pdna
complex
low
mn
chitosan
dda
kda
mnw
compar
high
mn
chitosan
dda
kda
mn
mandk
singh
demonstr
im
administr
mice
anterior
tibiali
muscl
bicistron
plasmid
encod
complex
nlinoleyl
low
mn
chitosan
noleyl
low
mn
chitosan
dda
kda
mw
led
sustain
express
maximum
week
follow
inject
singl
dose
nanoparticl
express
transgen
gradual
decreas
end
week
period
probabl
due
deactiv
promot
andor
turnov
muscl
fiber
recombin
protein
reach
blood
circul
therapeut
effect
confirm
control
blood
glucos
level
diabet
type
induc
murin
model
jean
et
al
also
succeed
effici
deliv
im
sc
low
mn
chitosan
dda
kda
mw
pdna
encod
nanoparticl
therapeut
effect
confirm
type
diabet
rat
model
zdf
dose
plasma
level
fivefold
higher
nontreat
anim
increas
plasma
insulin
concentr
sinc
first
gene
therapi
clinic
trial
initi
rosenberg
gene
therapi
clinic
trial
worldwid
approv
adenoviru
retroviru
wide
use
vector
gene
therapi
clinic
trial
cancer
treatment
liposom
polym
formul
nanocarri
dna
sirna
also
current
clinic
investig
exampl
liposom
dopa
cation
lipid
pei
appli
human
trial
pdna
deliveri
via
intranas
intralesion
intraves
administr
deliv
respect
cystic
fibrosi
transmembran
regul
gene
cftr
patient
cystic
fibrosi
leukocyt
microglobulin
patient
advanc
metastat
melanoma
gene
nonprotein
code
rna
gene
regulatori
sequenc
patient
superfici
bladder
cancer
also
system
administr
nanoparticl
form
linear
cyclodextrinbas
polym
cdp
human
transferrin
protein
tf
target
ligand
polyethylen
glycol
peg
cdppegtf
evalu
silenc
subunit
ribonucleotid
reductas
patient
solid
cancer
date
gene
therapi
clinic
trial
report
use
chitosanbas
pdna
sirna
nanoparticl
howev
clinic
trial
involv
chitosan
progress
includ
norwalk
vlp
vaccin
viruslik
particl
vlp
vaccin
adjuv
monophosphoryl
lipid
chitosan
studi
chitosan
use
mucoadhes
nasal
mucu
epitheli
cell
prolong
antigen
adher
tabl
summar
signific
human
studi
clinic
trial
use
chitosan
last
decad
success
nanoparticlebas
gene
therapi
depend
effect
absenc
seriou
side
effect
toxic
offtarget
effect
critic
factor
must
taken
consider
design
gene
deliveri
system
vivo
use
two
type
offtarget
effect
need
avoid
minim
interfer
nontarget
gene
express
ii
undesir
immun
stimul
recognit
nanoparticl
nanoparticl
compound
innat
system
offtarget
effect
associ
rnai
attract
attent
inde
rnai
recogn
interfer
express
mrna
share
partial
homolog
target
mrna
henc
import
care
select
sirna
sequenc
use
algorithm
perform
vitro
test
underestim
effect
chitosanbas
na
nanoparticl
induct
immun
respons
complet
elucid
except
gene
therapi
studi
aim
recombin
cytokin
express
immun
respons
induct
associ
antigenspecif
immun
lee
et
al
also
show
signific
amount
proinflammatori
cytokin
produc
human
prostat
cancer
cell
treat
chitosanbas
polysirna
glycol
nanoparticl
wiegand
et
al
show
depend
incub
time
concentr
high
mn
chitosan
kda
compar
low
mn
kda
kda
abl
stimul
releas
inflammatori
cytokin
hacat
cell
huang
et
al
suggest
cellular
uptak
chitosan
solubl
molecul
condens
nanoparticl
associ
cytotox
fact
viabil
cell
gener
affect
solubl
chitosan
nanoparticl
low
concentr
show
progress
declin
expos
increas
concentr
beyond
mgml
vitro
studi
show
mn
rang
kda
affect
cytotox
decreas
dda
polym
attenu
cytotox
latter
support
find
ekrami
shen
cytotox
directli
relat
nanoparticl
surfac
charg
densiti
wiegand
winter
et
al
confirm
high
mn
chitosan
kda
compar
low
mn
kda
neg
impact
hacat
cell
viabil
prolifer
vitro
addit
richardson
kolb
et
al
show
chitosan
differ
mn
kda
kda
kda
display
littl
cytotox
ccrfcem
cell
n
mgml
hemolyt
effect
vivo
chitosan
mice
gener
exce
gkg
bstdermon
wound
dress
aqueou
mixtur
chitosan
hydrochlor
acid
hcl
disodium
betaglycerol
phosphat
evalu
safeti
efficaci
bstdermon
repair
diabet
foot
ulcer
studi
stop
forfinanci
reason
canada
bstcargel
versu
microfractur
repair
articular
cartilag
lesion
knee
bstcargel
chitosan
glycerol
phosphat
solut
mix
whole
blood
patient
provid
polymerreinforc
blood
clot
improv
cartilag
repair
treatment
damag
cartilag
knee
bstcargel
microfractur
compar
microfractur
alon
evalu
amount
qualiti
cartilag
repair
tissu
bstcargel
treatment
result
cartilag
repair
higher
quantiti
qualiti
similar
safeti
profil
microfractur
known
orthoped
standard
care
canada
korea
spain
efficaci
safeti
chitosan
manag
hypercholesterolemia
random
multicent
placebocontrol
trial
chitosan
enzymat
polychitosamin
hydrolys
lowmw
kda
dda
efficaci
safeti
chitosan
sole
treatment
lower
ldlcholesterol
level
patient
mild
moder
level
cholesterol
sole
treatment
chitosan
effect
safe
lower
ldlc
concentr
patient
lowtomoder
hypercholesterolemia
effect
statin
chitosan
also
associ
signific
reduct
total
cholesterol
start
four
week
post
treatment
canada
studi
chronic
kidney
diseas
patient
hemodialysi
hyperphosphatemia
chitosanload
chew
gum
efficaci
safeti
three
time
day
week
regimen
patient
hyperphosphatemia
undergo
hemodialysi
patient
includ
studi
serum
inorgan
phosphoru
well
control
calcium
carbon
sevelam
hydrogen
chlorid
inform
avail
japan
norwalk
vaccin
studi
viruslik
particl
vlp
vaccin
adjuv
monophosphoryl
lipid
mpl
chitosan
safeti
immunogen
norwalk
vlp
vaccin
adjuv
norwalk
vlp
vaccin
administr
intranas
highli
immunogen
second
dose
vaccin
significantli
increas
level
specif
antibodi
serum
antibodi
respons
unit
state
product
inform
purpos
conclus
locat
phase
refer
poloxamerchitosan
situ
form
gel
prolong
retent
time
ocular
deliveri
gel
combin
thermoset
polym
poli
ethylen
oxid
poli
propylen
oxid
poli
ethylen
oxid
peoppopeo
poloxam
chitosan
mw
kda
dda
ophthalm
deliveri
system
improv
mechan
mucoadhes
properti
could
provid
prolong
retent
time
treatment
ocular
diseas
chitosan
increas
retent
time
fourfold
comparison
convent
solut
chitosan
confer
mucoadhes
forc
concentrationdepend
manner
brazil
analges
efficaci
safeti
novel
intranas
morphin
plu
chitosan
formul
compar
oral
intraven
rout
morphin
administr
postsurg
dental
pain
model
activ
nasal
spray
contain
morphin
mgml
solubil
aqueou
solut
combin
chitosan
glutam
mgml
efficaci
safeti
intranas
morphin
vs
oral
intraven
morphin
provid
postsurg
opioid
analgesia
moderatetosever
pain
singl
dose
intranas
morphin
mg
mg
safe
well
toler
provid
rapid
analgesia
patient
acut
moderatetosever
postsurg
pain
mg
dose
intranas
morphin
show
efficaci
profil
similar
mg
dose
intraven
morphin
treatment
demonstr
rapid
onset
efficaci
persist
throughout
assess
period
unit
state
longterm
clinic
outcom
percutan
inject
base
chitosan
complex
milican
treatment
small
hepatocellular
carcinoma
base
complex
milican
retain
radioact
materi
within
tumor
longterm
tumor
respons
safeti
percutan
base
complex
inject
therapi
small
hepatocellular
carcinoma
local
abl
treatment
among
treat
patient
long
period
followup
tumor
recur
patient
recur
anoth
intrahepat
site
cumul
local
recurr
rate
respect
surviv
rate
year
respect
korea
induct
protect
serum
respons
meningococc
bactericid
diphtherianeutr
antibodi
mucos
immunoglobulin
volunt
nasal
insuffl
neisseria
meningitidi
serogroup
c
conjug
vaccin
mix
chitosan
neisseria
meningitidi
serogroup
c
conjug
vaccin
mix
chitosan
formul
chitosan
glutam
effici
nasal
insuffl
neisseria
meningitidi
serogroup
c
conjug
vaccin
mix
chitosan
simpl
nasal
insuffl
exist
conjug
vaccin
chitosan
offer
inexpens
effect
needlefre
prime
boost
immun
serogroup
c
n
meningitidi
diphtheria
unit
kingdom
chitosan
deliveri
system
treatment
oral
mucos
vitro
vivo
studi
nystatin
incorpor
gel
compos
chitosan
differ
molecular
weight
mw
dda
effici
occlus
bioadhes
system
chitosan
base
gel
prophylaxi
andor
treatment
oral
mucos
comparison
commerci
suspens
concentr
nystatin
saliva
higher
gel
prepar
low
molecularweight
chitosan
nystatin
saliva
level
minimum
inhibitori
concentr
maintain
min
turkey
intranas
immun
genet
detoxifi
diphtheria
toxin
induc
cell
respons
human
enhanc
respons
toxinneutr
antibodi
formul
chitosan
powder
formul
contain
chitosan
mannitol
potenti
intranas
booster
immun
alon
chitosan
induc
system
cell
respons
respons
enhanc
follow
booster
immun
chitosan
correl
protect
level
toxinneutr
antibodi
intranas
boost
individu
ireland
nonallergen
charact
chitosanbas
system
mani
investig
perform
order
elucid
possibl
relationship
allergi
presenc
chitin
crustacean
import
issu
chitin
extract
crustacean
use
product
chitosan
chitosanderiv
biomed
applic
muzzarelli
reveal
review
conceptu
methodolog
error
differ
research
report
hasti
link
made
allergi
chitin
take
consider
contradictori
find
differ
research
report
muzzarelli
conclud
purifi
chitin
chitosan
free
protein
fat
contamin
could
induc
allerg
reaction
classifi
nonallergen
chemic
addit
result
mani
studi
converg
similar
conclus
chitin
stimul
innat
immun
respons
activ
macrophag
innat
immun
cell
lead
type
cytokin
product
downregul
type
allerg
immun
respons
strong
et
al
also
show
intranas
applic
chitin
microparticl
effect
treatment
reduc
serum
ige
airway
hyperrespons
lung
inflamm
mous
model
allergi
treatment
increas
cytokin
also
decreas
product
cytokin
involv
b
cell
product
allergenspecif
ige
date
research
group
report
allerg
respons
associ
use
chitosan
chitosanderiv
base
na
nanoparticl
howev
mani
investig
potenti
chitosanbas
dna
nanoparticl
dna
vaccin
allergi
treatment
roy
et
al
show
chitosan
mn
kda
base
pdna
nanoparticl
size
nm
code
domin
peanut
allergen
gene
deliv
oral
modifi
immun
system
mice
protect
food
allergeninduc
hypersensit
ige
histamin
level
well
anaphylact
respons
substanti
lower
vaccin
anim
compar
control
group
li
et
al
show
oral
vaccin
chitosan
mn
kda
dda
base
pdna
nanoparticl
nm
code
mite
dust
allergen
prevent
subsequ
sensit
cellregul
specif
ige
respons
increas
decreas
serum
studi
immunostimulatori
activ
report
use
chitosan
alon
howev
sinc
lee
et
al
da
silva
et
al
report
sizedepend
immunostimul
chitin
would
interest
investig
immunostimulatori
potenti
chitosan
particl
differ
size
liposom
lipoplex
nonvir
transfect
vehicl
plasmid
rnai
pose
toxic
concern
repeat
administr
vivo
lipidbas
deliveri
system
caus
phospholipidosi
intraven
inject
stabl
nalipid
particl
snalp
success
target
liver
silenc
apolipoprotein
b
apob
gene
mice
nonhuman
primat
howev
signific
transient
elev
serum
transaminas
aspart
transaminas
alanin
transaminas
indic
hepatocellular
necrosi
identifi
effect
dose
liposom
formul
na
known
induc
inflammatori
cytokin
includ
tumor
necrosi
factoralpha
interferongamma
relat
liver
damag
polyethylen
glycol
peg
modif
liposom
pegyl
purpos
reduc
toxic
also
found
elicit
acut
hypersensit
repeat
dose
similarli
highli
studi
cation
famili
synthet
polym
pei
possess
high
gene
transfer
effici
associ
signific
toxic
issu
limit
broad
use
clinic
trial
pei
cytotox
character
twophas
process
polycationcel
interact
induc
loss
cell
membran
integr
induct
apoptosi
insight
pei
toxic
highlight
import
polycationorganel
interact
ie
mitochondria
lysosom
induct
toxic
gener
cation
polym
display
less
toxic
associ
cytokin
induct
immun
activ
compar
cation
lipid
counterpart
chitosan
chitosan
deriv
nanocarri
gene
therapi
face
tradit
barrier
suscept
degrad
nucleas
cargo
low
cellular
membran
permeabl
low
solubl
physiolog
ph
lack
specif
order
increas
translat
bench
bedsid
effort
focus
chemic
biolog
modif
chitosan
order
increas
stabil
specif
endosom
escap
stabil
aggreg
nanocomplex
vivo
deliveri
may
achiev
graft
neutral
polym
chitosan
order
reduc
surfac
charg
increas
stabil
chitosanpolynucleotid
complex
kopinghoggard
et
al
demonstr
high
level
transfect
may
achiev
use
low
mn
chitosan
attempt
specif
target
cell
receptor
dna
deliveri
perform
use
pei
graft
chitosan
galactosyl
chitosan
galactosyl
chitosangraftpoli
vinylpyrrolidon
pvp
trimethyl
chitosan
oligom
ndodecyl
chitosan
deoxychol
acid
modifi
chitosan
ligand
attach
chitosan
specif
ligand
chitosanbas
nanocomplex
enhanc
vivo
biodistributionaccumul
desir
target
tissuescel
howev
system
administr
complex
expect
achiev
preferenti
uptak
desir
target
suitabl
target
moieti
appropri
incorpor
formul
mohammadi
et
al
coupl
specif
ligand
fapb
chitosandna
nanoparticl
via
electrostat
attract
order
target
lung
epitheli
cell
show
transfect
effici
chitosandnafapb
nanoparticl
size
nm
higher
chitosandna
nanoparticl
howev
vivo
studi
yet
perform
confirm
nanoparticl
effici
luo
et
al
design
new
sirna
nanocarri
target
specif
lung
cell
coupl
salbutamol
adrenoceptor
agonist
guanidinyl
chitosan
nanocarri
nm
size
remark
enhanc
efficaci
gene
silenc
vitro
vivo
use
transgen
mice
egfp
gene
silenc
therapeut
sirna
complex
new
categori
nanocarri
confirm
rnai
effici
vivo
anoth
innov
promis
approach
need
addit
character
explor
kumar
et
al
demonstr
simpl
extern
magnet
field
help
direct
nanoparticl
specif
site
vivo
magnet
nanoparticl
conjug
plasmid
dna
express
egfp
coat
chitosan
particl
inject
mice
tail
vein
direct
heart
kidney
mean
extern
magnet
also
chitosan
modif
consid
enhanc
function
deliveri
na
payload
effici
endosom
escap
nanoparticl
transfect
effici
improv
modifi
depolymer
trimethyl
chitosan
histidin
moieti
histidin
lead
osmot
swell
membran
disrupt
eventu
vesicular
escap
dna
imidazol
group
histidin
possess
pk
near
thu
absorb
proton
possess
buffer
capac
endosom
ph
rang
ph
possibl
increas
proton
spong
effect
summari
chitosan
investig
develop
deliv
na
nearli
two
decad
enter
stage
matur
first
result
human
clinic
trial
immin
mani
challeng
associ
product
accur
analys
specif
chitosan
overcom
result
identif
specif
system
high
effici
protein
express
plasmid
vector
gene
silenc
use
sirna
physicochem
biolog
basi
success
function
system
also
partli
elucid
vitro
lesser
extent
vivo
remain
challeng
effect
treat
human
diseas
includ
product
suffici
quantiti
highli
character
nanoparticl
featur
satisfi
regulatori
requir
match
current
capabl
protein
express
gene
silenc
target
safeti
profil
specif
clinic
indic
